US20190038897A1 - Systems and methods for intravascular catheter positioning and/or nerve stimulation - Google Patents

Systems and methods for intravascular catheter positioning and/or nerve stimulation Download PDF

Info

Publication number
US20190038897A1
US20190038897A1 US15/666,989 US201715666989A US2019038897A1 US 20190038897 A1 US20190038897 A1 US 20190038897A1 US 201715666989 A US201715666989 A US 201715666989A US 2019038897 A1 US2019038897 A1 US 2019038897A1
Authority
US
United States
Prior art keywords
electrodes
catheter
ecg signal
nerve
distal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US15/666,989
Other versions
US10195429B1 (en
Inventor
Viral S. Thakkar
Douglas G. Evans
Matthew J. Gani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lungpacer Medical Inc
Original Assignee
Lungpacer Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lungpacer Medical Inc filed Critical Lungpacer Medical Inc
Priority to US15/666,989 priority Critical patent/US10195429B1/en
Assigned to LUNGPACER MEDICAL INC. reassignment LUNGPACER MEDICAL INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GANI, MATTHEW J., EVANS, DOUGLAS G., Thakkar, Viral S.
Priority to US15/704,439 priority patent/US10039920B1/en
Priority to AU2018309630A priority patent/AU2018309630A1/en
Priority to EP18752951.6A priority patent/EP3661589A2/en
Priority to CN201880062545.1A priority patent/CN111225710A/en
Priority to JP2020505459A priority patent/JP7175027B2/en
Priority to PCT/US2018/043661 priority patent/WO2019027757A2/en
Priority to US16/222,299 priority patent/US11090489B2/en
Publication of US10195429B1 publication Critical patent/US10195429B1/en
Application granted granted Critical
Publication of US20190038897A1 publication Critical patent/US20190038897A1/en
Priority to US16/802,711 priority patent/US10926087B2/en
Priority to US17/371,316 priority patent/US20210330968A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3601Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of respiratory organs
    • A61B5/0422
    • A61B5/0452
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25Bioelectric electrodes therefor
    • A61B5/279Bioelectric electrodes therefor specially adapted for particular uses
    • A61B5/28Bioelectric electrodes therefor specially adapted for particular uses for electrocardiography [ECG]
    • A61B5/283Invasive
    • A61B5/287Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/24Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316Modalities, i.e. specific diagnostic methods
    • A61B5/318Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346Analysis of electrocardiograms
    • A61B5/349Detecting specific parameters of the electrocardiograph cycle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4887Locating particular structures in or on the body
    • A61B5/4893Nerves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/0551Spinal or peripheral nerve electrodes

Definitions

  • This disclosure relates to systems, devices, and methods for one or more of positioning an intravascular nerve stimulation catheter, selecting electrodes for nerve stimulation, or stimulating nerves.
  • Nerves and muscles may be stimulated by placing electrodes in, around, or near the nerves and muscles and by activating the electrodes by means of an implanted or external source of energy (e.g., electricity).
  • an implanted or external source of energy e.g., electricity
  • the diaphragm muscle provides an important function for the respiration of human beings.
  • the phrenic nerves normally transmit signals from the brain to cause the contractions of the diaphragm muscle necessary for breathing.
  • various conditions can prevent appropriate signals from being delivered to the phrenic nerves. These include: permanent or temporary injury or disease affecting the spinal cord or brain stem; Amyotrophic Lateral Sclerosis (ALS); decreased day or night ventilatory drive (e.g., central sleep apnea, Ondine's curse); and decreased ventilatory drive while under the influence of anesthetic agents and/or mechanical ventilation. These conditions affect a significant number of people.
  • ALS Amyotrophic Lateral Sclerosis
  • day or night ventilatory drive e.g., central sleep apnea, Ondine's curse
  • decreased ventilatory drive while under the influence of anesthetic agents and/or mechanical ventilation.
  • Intubation and positive pressure mechanical ventilation may be used for periods of several hours or several days, sometimes weeks, to help critically ill patients breathe while in intensive care units (ICU). Some patients may be unable to regain voluntary breathing and thus require prolonged or permanent mechanical ventilation. Although mechanical ventilation can be initially lifesaving, it has a range of significant problems and/or side effects.
  • Mechanical ventilation can be initially lifesaving, it has a range of significant problems and/or side effects.
  • a patient who is sedated and connected to a mechanical ventilator cannot breathe normally because the central neural drive to the diaphragm and accessory respiratory muscles are suppressed. Inactivity leads to muscle disuse atrophy and an overall decline in well-being. Diaphragm muscle atrophy occurs rapidly and can be a serious problem to the patient. According to a published study of organ donor patients (Levine et al., New England Journal of Medicine, 358: 1327-1335, 2008), after only 18 to 69 hours of mechanical ventilation, all diaphragm muscle fibers had shrunk on average by 52-57%. Muscle fiber atrophy results in muscle weakness and increased fatigability. Therefore, ventilator-induced diaphragm atrophy could cause a patient to become ventilator-dependent.
  • Embodiments of the present disclosure relate to, among other things, systems, devices, and methods for one or more of positioning an intravascular nerve stimulation catheter, selecting electrodes for nerve stimulation, or stimulating nerves.
  • Each of the embodiments disclosed herein may include one or more of the features described in connection with any of the other disclosed embodiments.
  • a method for positioning an intravascular catheter may include inserting the intravascular catheter into a venous system of a patient, wherein the catheter includes a plurality of electrodes, and multiple electrodes of the plurality of electrodes are configured to emit electrical signals; positioning a distal portion of the catheter in a first position; using one or more electrodes of the plurality of electrodes to acquire an ECG signal; based on the acquired ECG signal, adjusting the distal portion of the catheter to a second position different from the first position; identifying at least one first electrode of the plurality of electrodes to stimulate a first nerve; identifying at least one second electrode of the plurality of electrodes to stimulate a second nerve; and stimulating at least one of the first and second nerves to cause a contraction of a respiratory muscle.
  • inserting the intravascular catheter into the venous system may include inserting the intravascular catheter into: 1) at least one of a left subclavian, axillary, cephalic, cardiophrenic, brachial, radial, or left jugular vein, and 2) a superior vena cava;
  • the first position may be proximate an atrium of a heart of the patient, and the second position may be in a superior vena cava;
  • the ECG signal may be a first ECG signal, and the method may further comprise using one or more electrodes of the plurality of electrodes to acquire a second ECG signal;
  • the one or more electrodes used to acquire the first ECG signal may be positioned on a proximal portion of the catheter and may be configured to stimulate the first nerve, and the one or more electrodes used to acquire the second ECG signal may be positioned on a distal portion of the catheter and may be configured to stimulate the second nerve;
  • the method may further comprise using one or more electrodes of the plurality of
  • a method for positioning an intravascular catheter may include inserting the intravascular catheter into: 1) at least one of a left subclavian vein or a left jugular vein, and 2) a superior vena cava, wherein the catheter includes a plurality of electrodes, and the plurality of electrodes includes a proximal set of electrodes positioned proximate a left phrenic nerve and a distal set of electrodes positioned proximate a right phrenic nerve; using one or more electrodes of the plurality of electrodes to acquire an ECG signal; based on a change in the ECG signal, withdrawing the catheter away from a heart of a patient; stimulating the left phrenic nerve using one or more electrodes of the proximal set of electrodes; and stimulating the right phrenic nerve using one or more electrodes of the distal set of electrodes.
  • a method for positioning an intravascular catheter may include inserting the intravascular catheter into a venous system of a patient, wherein the catheter includes a plurality of proximal electrodes and a plurality of distal electrodes; using one or more electrodes of the plurality of proximal electrodes to acquire a first ECG signal, and using one or more electrodes of the plurality of distal electrodes to acquire a second ECG signal; comparing the first ECG signal to the second ECG signal; based on the comparison between the first ECG signal and the second ECG signal, adjusting a position of the catheter; stimulating the first nerve using one or more of the plurality of proximal electrodes; and stimulating the second nerve using one or more of the plurality of distal electrodes.
  • any method described herein may additionally or alternatively include one or more of the following features or steps: the first nerve may be a left phrenic nerve, and the second nerve may be a right phrenic nerve; comparing the first ECG signal to the second ECG signal may include comparing an amplitude of a portion of the first ECG signal to an amplitude of a portion of the second ECG signal; the step of comparing may occur a plurality of times during the inserting step; adjusting the position of the catheter may include moving the catheter away from a heart; at least one of stimulating the first nerve or stimulating the second nerve may cause a contraction of a diaphragm; or the method may further include sensing activity of the first nerve using one or more of the proximal electrodes and sensing activity of the second nerve using one or more of the distal electrodes
  • a method for positioning an intravascular catheter may include inserting the intravascular catheter into: 1) at least one of a left subclavian vein or a left jugular vein, and 2) a superior vena cava, wherein the catheter includes a plurality of proximal electrodes configured to be positioned proximate a left phrenic nerve and a plurality of distal electrodes configured to be positioned proximate a right phrenic nerve; at multiple positions of the catheter during the inserting step, using one or more electrodes of the plurality of proximal electrodes to acquire a first ECG signal, and using one or more electrodes of the plurality of distal electrodes to acquire a second ECG signal; comparing the first ECG signal to the second ECG signal at several of the multiple positions; based on the comparisons of the first ECG signal to the second ECG signal, determining a desired position of the catheter for nerve stimulation; stimulating the left phrenic nerve using one or more of the plurality of proximal electrode
  • any method described herein may additionally or alternatively include one or more of the following features or steps: the method may further include advancing a distal end of the catheter into a region proximate an atrium of a heart; one of the multiple positions may be a position in which the distal end of the catheter is proximate the atrium of the heart, and in the position, the comparison may indicate a difference between an amplitude of the first ECG signal and an amplitude of the second ECG signal that exceeds a predetermined value; the method may further include moving the catheter away from the heart; stimulating the left phrenic nerve may cause a diaphragm contraction, and stimulating the right phrenic nerve may cause a diaphragm contraction; the proximal electrodes used to acquire the first ECG signal may be configured to stimulate the left phrenic nerve, and the distal electrodes used to acquire the second ECG signal may be configured to stimulate the right phrenic nerve.
  • FIG. 1 illustrates a nerve stimulation system with an intravascular catheter positioned within a patient, according to an exemplary embodiment.
  • FIG. 2 illustrates a nerve stimulation system having a portable control unit, according to an exemplary embodiment.
  • FIG. 3 illustrates a wireless configuration of a nerve stimulation system, according to an exemplary embodiment.
  • FIG. 4 illustrates an intravascular catheter having a helical portion, according to an exemplary embodiment.
  • FIG. 6 illustrates an intravascular catheter having an ultrasound transducer, according to an exemplary embodiment.
  • FIG. 7 illustrates a block diagram of a nerve stimulation system having an intravascular catheter and a control unit, according to an exemplary embodiment.
  • Electrodes When electrically stimulating nerves or muscles, a variety of goals may be considered. First, it may be desirable to place the electrodes in proximity to the phrenic nerves. Second, it may be desirable to avoid placing electrodes in close proximity to the sinoatrial (SA) node, atrioventricular (AV) node, or the His-Purkinje system located in heart tissue, as electrical stimulation of these anatomical features may cause arrhythmia. Third, when using a device that includes multiple electrodes, it may be desirable to identify particular electrodes that are in close proximity to the nerve. Identifying the proper electrodes may minimize the electrical charge required to effectively stimulate the nerves. Finally, as with any medical procedure, the risk of injury to the patient increases with the length and complexity of the medical procedure. Accordingly, it may be desirable to minimize the length of any procedure to electrically stimulate nerves or muscles.
  • the present disclosure is drawn to systems, devices, and methods for one or more of positioning an intravascular catheter for nerve stimulation, selecting electrodes for nerve stimulation, and stimulating nerves.
  • embodiments of the present disclosure may use various positioning features to obtain information useful for positioning a transvascular nerve stimulation catheter, or may use information gathered by sensors to select electrodes and parameters for nerve stimulation.
  • FIG. 1 illustrates a system 10 that includes a transvascular nerve stimulation catheter 12 and a control unit 14 .
  • Catheter 12 may include a plurality of electrodes 34 .
  • Catheter 12 may be operably connected (e.g., hardwired, wireless, etc.) to a control unit 14 .
  • the control unit 14 may be programmed to perform any of the functions described herein in connection with system 10 .
  • the control unit 14 may include a remote controller 16 to allow a patient or health professional to control operation of the control unit 14 at a distance from the control unit 14 .
  • the controller 16 may include a handheld device, as illustrated in FIG. 1 .
  • controller 16 may include a footswitch/pedal, a voice-activated, touch-activated, or pressure-activated switch, or any other form of a remote actuator.
  • the control unit 14 may include a touch screen 18 and may be supported by a cart 20 .
  • catheter 12 may be positioned to electrically stimulate one or both of the left and right phrenic nerves 26 , 28 to cause contraction of the diaphragm muscle 30 to initiate or support a patient breath.
  • the proximal portion of catheter 12 may be positioned in a left jugular vein 32
  • the distal portion of catheter 12 may be positioned in superior vena cava 24 .
  • catheter 12 can be placed into and advanced through other vessels providing access to the locations adjacent the target nerve(s) (e.g., phrenic nerves), such as: the jugular, axillary, cephalic, cardiophrenic, brachial, or radial veins.
  • catheter 12 may use other forms of stimulation energy, such as ultrasound, to activate the target nerves.
  • the system 10 can target other respiratory muscles (e.g., intercostal) either in addition to, or alternatively to, the diaphragm 30 .
  • the energy can be delivered via one or more methods including transvascular, subcutaneous, nerve cuffs, transdermal stimulation, or other techniques known in the field.
  • FIG. 2 illustrates an alternative example of system 10 , in which control unit 14 ′ is portable.
  • Portable control unit 14 ′ may include all of the functionality of control unit 14 of FIG. 1 , but it may be carried by a patient or other user to provide the patient with more mobility.
  • the patient can wear control unit 14 ′ on a belt, on other articles of clothing, or around his/her neck, for example.
  • control unit 14 ′ may be mounted to a patient's bed to minimize the footprint of system 10 in the area around the patient, or to provide portable muscle stimulation in the event a bed-ridden patient needs to be transported or moved to another location.
  • the system of FIG. 2 may include a controller 16 , shown as a handheld controller 16 .
  • Handheld controller 16 may include buttons 17 , 19 that can be pressed by a patient or other user to control breathing patterns. In one example, pressing one of buttons 17 , 19 can initiate a “sigh” breath, which may cause a greater volume of air to enter the patient's lungs than in a previous breath.
  • a sigh breath may result when electrodes 34 of catheter 12 are directed to stimulate one or more of the phrenic nerves 26 , 28 at a higher level than a normal breath (i.e., a stimulation train having a longer duration of stimulation or having pulses with a higher amplitude, pulse width, or frequency).
  • Higher amplitude stimulation pulses can recruit additional nerve fibers, which in turn can engage additional muscle fibers to cause stronger and/or deeper muscle contractions.
  • Extended pulse widths or extended durations of the stimulation train can deliver stimulation over longer periods of time to extend the duration of the muscle contractions.
  • longer pulse widths have the potential to help expand the lower lung lobes by providing greater or extended negative pressure around the outside of the lungs. Such negative pressure has the potential to help prevent or mitigate a form of low pressure lung injury known as atelectasis.
  • the increased stimulation of the one or more phrenic nerves 26 , 28 may result in a more forceful contraction of the diaphragm 30 , causing the patient to inhale a greater volume of air, thereby providing a greater amount of oxygen to the patient. Sigh breaths may increase patient comfort.
  • buttons 17 , 19 may allow the patient or other user to start and stop stimulation therapy, or to increase or decrease stimulation parameters, including stimulation charge (amplitude ⁇ pulse width), frequency of pulses in a stimulation train, or breath rate.
  • LED indicators or a small LCD screen (not shown) on the controller may provide other information to guide or inform the operator regarding the stimulation parameters, the feedback from the system sensors, or the condition of the patient.
  • Remote controller 16 may be used as described in connection with FIGS. 1 and 2 . In other examples, remote controller 16 may be in the form of a smartphone, tablet, watch or other wearable device.
  • catheter 12 may include a stimulation array comprising a plurality of electrodes 34 or other energy delivery elements.
  • electrodes 34 may be surface electrodes located on an outer wall of catheter 12 .
  • electrodes 34 may be positioned radially inward relative to the outer wall of catheter 12 (e.g., exposed through openings in the outer wall).
  • the electrodes 34 may include printed electrodes as described in U.S. Pat. No. 9,242,088, which is incorporated by reference herein (see below).
  • Electrodes 34 may extend partially around the circumference of catheter 12 . This “partial” electrode configuration may allow electrodes 34 to target a desired nerve for stimulation, while minimizing application of electrical charge to undesired areas of the patient's anatomy (e.g., other nerves or the heart).
  • catheter 12 may include a proximal set 35 of electrodes 34 configured to be positioned proximate to and stimulate left phrenic nerve 26 and a distal set 37 of electrodes 34 configured to be positioned proximate to and stimulate right phrenic nerve 28 .
  • electrodes 34 may be arranged in rows extending along the length of catheter 12 .
  • proximal set 35 may include two rows
  • distal set 37 may include two rows.
  • control units described herein can have any of the functionality of the control units described in the above-referenced patent documents (e.g., the control units described herein can implement the methods of nerve stimulation described in the incorporated documents).
  • one or more electrodes 34 may be selected from the proximal set 35 for stimulation of left phrenic nerve 26 , and one or more electrodes 34 may be selected from the distal set 37 for stimulation of right phrenic nerve 28 .
  • Catheter 12 may stimulate nerves using monopolar, bipolar, or tripolar electrode combinations, or using any other suitable combination of electrodes 34 .
  • a second or third stimulation array can be used to stimulate other respiratory muscles.
  • the controller and sensors described herein may be used to coordinate stimulation to achieve the desired muscle activation, breath, or level of respiratory support.
  • Catheter 12 may further include one or more lumens. Each lumen may extend from a proximal end of catheter 12 to a distal end of catheter 12 , or to a location proximate the distal end of catheter 12 .
  • the lumens may contain medical devices, such as a guidewire or an optical fiber camera.
  • the one or more lumens may be used for any suitable purpose, such as drawing blood samples or providing a pathway for delivering medications into the patient.
  • lumens may contain or be fluidly connected to sensors, such as blood gas sensors or pressure sensors.
  • catheter 12 may each illustrate different features and different combinations of features.
  • catheter 12 may include any combination of the features that are described herein. Accordingly, the features of catheter 12 are not limited to the specific combinations shown in the various figures.
  • a hub 36 may be connected to the proximal end of catheter 12 .
  • Hub 36 may include a conductive surface and can act as a reference electrode during monopolar stimulation or sensing.
  • hub 36 may be sutured on a patient's skin.
  • hub 36 may be used as an ECG electrode.
  • FIG. 4 illustrates catheter 12 inserted into left jugular vein 32 and superior vena cava 24 .
  • catheter 12 includes a plurality of electrodes 34 , with proximal electrodes 34 positioned near left phrenic nerve 26 and distal electrodes 34 positioned near right phrenic nerve 28 .
  • Catheter 12 may further include three lumens (not shown) that connect with extension lumens 38 , 40 , 42 that extend proximally from hub 36 .
  • the distal portion of catheter 12 may be configured to assume a helical shape 44 when positioned within the patient. Helical shape 44 may help anchor catheter 12 to the vessel wall to stabilize catheter 12 during nerve stimulation.
  • helical shape 44 may be obtained by using a stiffening wire inserted into a lumen of catheter 12 via an extension lumen 38 , 40 , or 42 .
  • the stiffening wire may include a shape-memory material (e.g., Nitinol) biased to a helical shape, stainless steel, or any other suitable material.
  • the portion of catheter 12 configured to assume the helical shape 44 may include materials having a lower stiffness than other portions of catheter 12 .
  • the materials along helical shape 44 may be thinner or more flexible than the materials along the remaining length of catheter 12 .
  • catheter 12 may include a temperature-activated shape memory material (e.g., Nitinol) along a portion of its length, such that the shape-memory material of catheter 12 may have a substantially straight shape at room temperature and may assume a helical shape when heated within the patient's body.
  • a temperature-activated shape memory material e.g., Nitinol
  • each of the extension lumens 38 , 40 , and 42 may end in a proximal-most port 38 a , 40 a , and 42 a , respectively.
  • the lumens internal to catheter 12 may terminate in one or more distal ports.
  • internal lumens that communicate with lumens 38 , 40 , and 42 terminate at a distal port 48 , medial port 50 , and proximal port 52 , respectively.
  • Lumens 38 , 40 , 42 and their corresponding internal lumens may be used to transport fluid to and from the patient, such as to deliver medications or withdraw blood or other bodily fluids.
  • FIG. 5 illustrates an optical fiber camera 46 inserted into lumen 38 , extending through a corresponding internal lumen, and exiting from distal port 48 .
  • FIG. 6 illustrates another example of catheter 12 .
  • Catheter 12 is similar to the catheter of FIG. 5 , except electrodes 34 may be formed by conductive inks (such as silver, gold, graphine, or carbon flakes suspended in polymer or other media) printed on the surface of catheter 12 , as described in U.S. Pat. No. 9,242,088, incorporated by reference herein (see above). These conductive inks may be deposited and adhered directly onto catheter 12 and sealed, except for the exposed electrodes 34 , with an outer polyurethane or other flexible insulative film.
  • conductive inks such as silver, gold, graphine, or carbon flakes suspended in polymer or other media
  • the exposed electrodes 34 may be coated (e.g., with titanium nitride) for purposes such as one or more of: enhancing electrical properties, such as conductivity and surface area; providing corrosion resistance; and reducing the potential for formation of silver oxide, which could be toxic.
  • the conductive ink trace of distal electrodes may travel proximally along catheter 12 past the more proximal electrodes 34 .
  • FIG. 6 further illustrates catheter 12 having an ultrasound transducer 54 at a distal end of catheter 12 , which will be described further below.
  • FIG. 7 illustrates a block diagram of the various components of system 10 .
  • the electrodes 34 a - 34 j , hub 36 , and lumens 38 , 40 , 42 , 58 , and 60 may be part of catheter 12 described herein.
  • Catheter 12 may have any number of electrodes and any number of lumens. Five lumens are illustrated in FIG. 7 , but in different examples, the catheter may include one, two, three, four, or more than five lumens.
  • catheter 12 may have three lumens (e.g., extension lumens 38 , 40 , 42 and corresponding internal lumens), which each may hold one or more of a guidewire or optical fiber camera, or may be used for fluid delivery or blood sample extraction (box 43 ).
  • catheter 12 may include four lumens, with one lumen 58 holding or fluidly connected to a pressure sensor 90 , one lumen 60 holding or fluidly connected to a blood gas sensor 62 , and the other two lumens holding a guidewire or optical fiber camera and/or being used for fluid delivery or blood sample extraction.
  • any lumen of system 10 may contain or be fluidly connected to any of the devices (e.g., sensors, guidewire, optical fiber camera) described herein and/or may be used for any of the functions described herein (e.g., fluid delivery, blood sample extraction).
  • System 10 may include a controller 64 , which may be part of any of the control units described herein. Each of the components of system 10 may be operably coupled to the controller 64 , and controller 64 may manage operation of electrodes 34 during nerve stimulation, control the gathering of information by various sensors and electrodes 34 , and control fluid delivery or extraction. It should be understood that the various modules described herein may be part of a computing system and are separated in FIG. 7 for explanatory purposes only; it is not necessary for the modules to be physically separate.
  • Electrodes 34 a - 34 j may be electronically coupled to switching electronics 56 , which may be communicably coupled to controller 64 . As shown in FIG. 7 , a portion of electrodes 34 may be distal electrodes 34 a - 34 d , and a portion of electrodes 34 may be proximal electrodes 34 g - 34 j . Other electrodes 34 , such as electrodes 34 e and 34 f , may be positioned between the proximal and distal electrodes and, depending on the placement of catheter 12 , may be used for stimulating either left or right phrenic nerves 26 , 28 . Hub 36 also may be connected to switching electronics 56 and may be used as an electrode.
  • Electrodes 34 a - 34 j may be used for both electrically stimulating nerves and for gathering physiological information.
  • a first combination of electrodes e.g., one, two, three, or more electrodes
  • a second combination of electrodes e.g., one, two, three, or more electrodes
  • a second stimulation module channel 72 for stimulation of a second nerve (e.g., the left phrenic nerve).
  • Electrical signals may be sent from the first and second stimulation module channels 70 , 72 to the electrode combinations to cause the electrodes to stimulate the nerves.
  • more than two electrode combinations e.g., 3, 4, or more
  • system 10 may include more than two stimulation module channels.
  • Electrodes 34 a - 34 f may be further configured to sense physiological information from a patient, such as nerve activity, ECG, or electrical impedance, as will be described further below.
  • one or more of electrodes 34 a - 34 f may be electronically coupled to a signal acquisition module 68 .
  • Signal acquisition module 68 may receive signals from electrodes 34 .
  • Switching electronics 56 may selectively couple electrodes 34 to first stimulation module channel 70 , second stimulation module channel 72 , or signal acquisition module 68 .
  • an electrode 34 e.g., electrode 34 a
  • switching electronics 56 may be coupled via switching electronics 56 to signal acquisition module 68 .
  • a pair of electrodes e.g., electrodes 34 b and 34 d
  • those electrodes may be coupled via switching electronics 56 to first stimulation module channel 70 .
  • Electrodes 34 g and 34 h may be coupled via switching electronics 56 to second stimulation module channel 72 .
  • Switching electronics 56 may change which electrodes 34 are used for stimulation and which are used for sensing at any given time.
  • any electrode 34 can be used for nerve stimulation and any electrode 34 can be used for sensing functions described herein.
  • each electrode 34 may be configured to stimulate nerves, and each electrode 34 may be configured to sense physiological information.
  • Signal acquisition module 68 may further be coupled to one or more sensors configured to gather physiological information from a patient.
  • system 10 may include one or more of blood gas sensor 62 or pressure sensor 90 . These sensors may be located in lumens of catheter 12 , outside of the patient in fluid communication with a lumen, on an outer surface of catheter 12 , or in any other suitable location.
  • blood gas sensor 62 may be housed in or fluidly connected to lumen 60
  • pressure sensor 90 may be housed in or fluidly connected to lumen 58 .
  • Blood gas sensor 62 may measure the amount of O 2 or CO 2 in the patient's blood.
  • Pressure sensor 90 may measure the central venous pressure (CVP) of the patient.
  • CVP central venous pressure
  • Signal acquisition module 68 may transmit the signals received from one or more of electrodes 34 , blood gas sensor 62 , and/or pressure sensor 90 to the appropriate processing/filtering module of system 10 .
  • signals from pressure sensor 90 may be transmitted to a central venous pressure signal processing/filtering module 84 , where the signals are processed and filtered to aid in interpretation of CVP information.
  • signals from blood gas sensor 62 may be transmitted to a blood gas signal processing/filtering module 86 for processing and filtering to determine blood gas levels.
  • Signals from electrodes 34 when they are used for sensing, may be sent to nerve signal processing/filtering module 80 , ECG signal processing/filtering module 82 , or impedance signal processing/filtering module 88 , as appropriate.
  • Signals from electrodes 34 or other sensors may be sent to amplification module 78 , if necessary, to amplify the signals prior to being sent to the appropriate processing/filtering module.
  • Controller 64 may further communicate with display 74 , which may serve as a user interface and may have a touch screen 18 (see FIG. 1 ).
  • System 10 may further include software/firmware 76 , which may contain the instructions necessary for carrying out the various functions described herein.
  • system 10 may include data storage 79 , for storing information gathered during sensing operations of catheter 12 , and/or for storing instructions related to the operation of any of the modules or instructions for carrying out any of the functions described herein.
  • Catheter 12 may include a variety of positioning features that may help a user to position catheter 12 within a patient. Some positioning features may be visualization aids, such as optical fiber camera 46 shown in FIG. 5 or ultrasound transducer 54 shown in FIG. 6 . Other positioning features may be sensors to sense physiological parameters, such as pressure sensor 90 . Electrodes 34 , which can be used to stimulate a nerve, also may be used as sensors to gather information that can then be used to position catheter 12 . For example, electrodes 34 may gather information related to nerve activity (e.g., the left or right phrenic nerve), ECG signals, and/or impedance. Accordingly, a sensing electrode 34 may be considered a positioning feature. Each of the positioning features and how they are used to help position catheter 12 will be described in further detail below.
  • Catheter 12 may include any combination of positioning features, including one or more visualization aids, sensors (e.g., pressure), or electrodes capable of sensing various types of information.
  • the control units described herein whether on a cart, wearable on a patient, or wireless, may be configured to process information gathered by the various positioning features described herein (e.g., visualization aids, sensors, and electrodes), as well as perform the various computerized functions described herein.
  • ultrasound transducer 54 may be used in addition to or instead of optical fiber camera 46 to obtain information useful for positioning catheter 12 within the patient.
  • Ultrasound transducer 54 may be secured temporarily or permanently to the exterior of catheter 12 , as shown in FIG. 6 , or may be positioned temporarily or permanently within a lumen of catheter 12 (e.g., positioned to extend from the distal end of a lumen of catheter 12 ).
  • Positioning ultrasound transducer 54 near the distal tip of catheter 12 may allow the user to view the inside of vessels and also ensure that the tip of catheter 12 is not positioned in an undesired location (e.g., in the atrium of the heart).
  • ultrasound transducer 54 may allow visualization of a heart valve, which could indicate that the catheter 12 has entered the atrium and may need to be retracted.
  • the ultrasound images may provide information (e.g., calculated or visual) about the diameter of blood vessels and/or blood flow within the vessels. The user may then use vessel diameter information, blood flow, and real time images of the inside of the patient's vessels to position catheter 12 in a desired position.
  • information e.g., calculated or visual
  • CVP measurements from pressure sensor 90 may further aid in positioning catheter 12 within the patient. Normal values may vary between 4-12 cm H 2 O.
  • the CVP waveform may change based on the location, relative to the patient's heart, of the port (e.g., 46 , 48 , or 50 ) in communication with pressure sensor 90 . In one example, CVP measurements may decline as the relevant port approaches the patient's heart. A user may read the changing CVP waveforms to help position the catheter 12 in a desired location relative to the patient's heart.
  • the CVP waveform has several components.
  • the (a) wave corresponds to the right atrial contraction and correlates with the P wave on the ECG.
  • the (c) wave corresponds to the cusp of the tricuspid valve protruding backwards through the atrium, as the right ventricle begins to contract.
  • the (c) wave correlates with the end of the QRS complex on the ECG.
  • the (x) descent corresponds to the movement of the right ventricle, which descends as it contracts. The downward movement decreases the pressure in the right atrium. At this stage, there is also atrial diastolic relaxation, which further decreases the right atrial pressure.
  • the (x) descent happens before the T wave on the ECG.
  • the (v) wave occurs as blood fills the right atrium and hits the tricuspid valve, causing a back-pressure wave.
  • the (v) wave occurs after the T wave of the ECG.
  • the (y) descent is a pressure decrease caused by the tricuspid valve opening in early ventricular diastole and occurs before the P wave of the ECG.
  • the amplitudes of a, c, x, v, y may change depending on the position of the catheter with respect to the heart.
  • the signature change of the CVP waveform can guide in the placement of catheter 12 .
  • a method for positioning intravascular catheter 12 may include positioning catheter 12 in a first position in a venous system of a patient, wherein catheter 12 includes a plurality of electrodes 34 and at least one lumen extending from a proximal end of catheter 12 to a distal end of catheter 12 , and each electrode 34 of the plurality of electrodes 34 is configured to emit electrical signals to stimulate a nerve; measuring a central venous pressure of the patient using a pressure sensor 90 fluidly connected to the at least one lumen; and based on the central venous pressure, adjusting catheter 12 to a second position different from the first position.
  • Nerve signals acquired by electrodes 34 also may be used to aid in positioning catheter 12 within a patient.
  • the electrical signal from a nerve may be amplified by amplification module 78 and processed by nerve signal processing/filtering module 80 .
  • the amplified and filtered signals from one or more electrodes 34 then may be compared to an expected signal from the targeted nerve (e.g., left or right phrenic nerve) to identify electrodes 34 in close proximity to the target nerve and to identify the optimal one or more electrodes for nerve stimulation. For example, electrodes 34 returning a higher strength and/or higher quality signal may be located closer to the target nerve.
  • Phrenic nerve activity can be recorded using bipolar or monopolar electrodes.
  • Phrenic nerve discharge can be amplified and filtered (e.g., 100 Hz to 5 kHz), and a moving average can be obtained using a third-order Paynter filter with a 20 or 50 ms time constant.
  • Phrenic nerve discharge also can be filtered at 10 Hz to 5 kHz for analysis of spectral composition. A sampling rate of 1-10 kHz can be used to capture the nerve activity.
  • the parameters acquired during nerve activity sensing can be used to detect if the signal is from the phrenic nerve or another nerve.
  • Sensed parameters can include a number of physiological parameters, such as amplitude, inspiration duration, and/or breathing rate. For example, if the sensed amplitude shows proximity of the electrodes 34 to the nerve and the nerve is a phrenic nerve, the duration of pulses in a train should match the sensed inspiration duration, and the frequency of the trains should match the sensed breathing rate.
  • the sensed signals from a nerve can be compared to known nerve signatures (e.g., of phrenic nerves) to confirm that the nerve signal is from the desired nerve.
  • Electrodes 34 may be used to acquire ECG signals, with hub 36 optionally being used as a reference electrode.
  • the ECG signal (e.g., morphology, amplitudes, and spectral content) may vary depending on the location, relative to the patient's heart, of the electrodes being used to measure the signal. Monitoring changes in the ECG signal as catheter 12 is being positioned may aid in identifying desired or undesired placement. For example, it may be undesired for catheter 12 to be placed in the atrium of the patient's heart.
  • one of the distal electrodes 34 on catheter 12 may be designated as a probe.
  • Other electrodes along the length of catheter 12 and in some cases in contact with the skin of the patient, may be used to detect an ECG signal, which can optionally be displayed by control unit 14 via screen 18 .
  • Catheter 12 may be advanced through superior vena cava 24 towards the heart. As catheter 12 enters a region proximate the right atrium, or enters the right atrium, the P-wave portion of the ECG may become elevated and create an augmented peaked P-wave, indicating that the tip of the catheter 12 lies in or very close to the right atrium.
  • the positive deflection in the P-wave occurs when current flows to the probing electrode, and a negative deflection when it flows away.
  • the P-wave depolarizes down the right atrium from the SA node, away from an electrode 34 in superior vena cava 24 , and is therefore negative.
  • the amplitude of the P-wave is related to the inverse square rule, whereby the amplitude is inversely proportional to the square of the distance from the current source.
  • the P-wave increases greatly in negative amplitude as catheter 12 approaches the atrium. When the tip enters the atrium, it is just beyond the SA node, and the first portion of the P-wave depolarizes towards it. This results in a brief, small positive deflection followed instantly by a deep negative deflection.
  • a distal combination of electrodes 34 e.g., a distal pair
  • a proximal combinations of electrodes 34 e.g., a proximal pair
  • the P-waves can be compared using standard signal processing techniques and a delta value can be determined as the catheter 12 is advanced through the vessel (e.g. superior vena cava 24 ) towards the heart. As catheter 12 is advanced in close proximity to or into the atrium, the delta value will change significantly, exceeding a predetermined value.
  • the system 10 can provide an indicator to the operator, as described previously, and catheter 12 can be withdrawn 1 to 2 cm.
  • This method can also utilize one or more reference electrodes 34 located along the length of the catheter or positioned externally on the patient's body.
  • the impedance presented to injected current may be dependent on the conductivity of the fluid, or adjacent tissue, in the local area between a pair of sensing electrodes 34 .
  • the conductivity further may depend on the cross-sectional area of the blood vessel at the site of the sending electrodes 34 .
  • the impedance of an electrode 34 may vary depending on the medium in which it is resting. For example, an electrode 34 placed in a relatively large body of conductive fluid may have a lower impedance than one resting against a vessel wall. The impedance of an electrode 34 can therefore be used to determine whether it is adjacent to a vessel wall or resting in a larger body of conductive fluid.
  • Electrodes 34 that are on a proximal portion of catheter 12 may have a higher impedance than other electrodes 34 , because the proximal portion of catheter 12 may be positioned in tissue (e.g., fatty) near an insertion site, rather than resting in the fluid of a blood vessel. Electrodes 34 farther down the shaft of catheter 12 , towards a central portion of catheter 12 , might have progressively lower impedances as the diameter of the vessel increases (e.g., as the vessel approaches superior vena cava 24 ). Electrodes 34 on the portion of catheter 12 that is floating in fluid in superior vena cava 24 might have a low impedance.
  • Electrodes 34 on the distal portion of catheter 12 might be in direct contact with the vessel wall and therefore may have a higher impedance.
  • a graph of the impedances of all of the electrodes 34 in this example may have a U-shaped curvature, as impedances may be higher at each end of catheter 12 and lower towards the central portion of catheter 12 .
  • the change in impedance of an electrode 34 as it progresses through the patient's vessels can provide information about the location of that electrode 34 .
  • the differences in impedances of electrodes 34 along the length of catheter 12 may provide information about the placement of catheter 12 .
  • catheter 12 may be placed in a vessel that varies in diameter, with distal electrodes 34 resting in a desired vessel (e.g., in superior vena cava 24 ).
  • the impedances of different, more proximal electrodes would be expected to vary depending on their position in the venous system.
  • catheter 12 when placed in a desired position, would be expected to include: 1) electrodes 34 whose impedances are reduced as the electrodes 34 approach the wall of a vessel (e.g., superior vena cava 24 ); and 2) electrodes 34 having impedance profiles with a desired shape.
  • measured impedances may be compared to impedance thresholds or profiles stored in data storage 79 , to determine if one or more electrodes 34 are properly placed.
  • the impedances of distal electrodes can be compared to the impedances of proximal electrodes as the catheter 12 is advanced through superior vena cava 24 towards the atrium. As the distal electrodes enter the atrium, the difference between the distal and proximal impedance measurements may exceed a predetermined threshold allowing the system 10 to provide an indication to the operator. Catheter 12 can then be withdrawn (or advanced depending on the application) to the desired location. Signal filtering, processing, and analytical techniques known in the art can be used to assess the impedance measurements in real time.
  • a catheter 12 that is under-inserted may have few or no electrodes 34 resting in the desired vessel (e.g., superior vena cava 24 ), which would result in electrode impedance profiles having different shapes than the desired shape.
  • a catheter 12 that is over-inserted may have one or more electrodes 34 that are close to, or in contact with, the atrium, which may also result in impedance profiles having different shapes than the desired shape.
  • the impedance of one or more electrodes 34 is monitored as catheter 12 is inserted into the patient and electrodes 34 move through the patient's venous system. Changes in the impedance profiles can be displayed to the health professional performing the insertion, and the impedance profiles can be used to confirm proper placement of catheter 12 .
  • catheter 12 may include a strain gauge and/or an accelerometer (not shown). Either the strain gauge or the accelerometer may be placed at or near the distal end of catheter 12 , in one of the lumens. The strain gauge could detect flex in a distal portion of catheter 12 , and the accelerometer could detect movement/acceleration of the distal portion of catheter 12 . Information from the strain gauge and/or accelerometer could be used to determine whether the distal end of catheter 12 is in the atrium (e.g., heartbeats may cause movement of the distal end of catheter 12 ). The strain gauge or the accelerometer could be an integral, permanent part of catheter 12 or could be positioned in a lumen of catheter 12 temporarily during positioning of catheter 12 .
  • Nerve signals acquired by sensing electrodes 34 may be used to select electrodes 34 for nerve stimulation. Electrodes 34 that are closer to a target nerve may sense nerve activity having a higher amplitude, while electrodes 34 that are farther from a target nerve may sense nerve activity having a lower amplitude. If a greater diaphragm response is desired, electrodes 34 that are closer to the nerve, as determined based on received nerve activity signals, may be selected for nerve stimulation. In other cases, if less diaphragm response is desired, electrodes 34 that are farther from the nerve, as determined based on received nerve activity signals, may be selected for nerve stimulation.
  • Typical nerve signals for, e.g., phrenic nerves follow a pattern that has distinct characteristics (e.g., spectral characteristics and modulation over time).
  • the sensed nerve signals from different electrodes 34 can be analyzed for their spectral and temporal characteristics.
  • the optimal electrodes 34 can be selected based on the amplitude of the signal and how strongly the signal correlates to the typical pattern.
  • a fast Fourier transform can be used to provide a correlation factor to a reference signal in near real-time.
  • the sensed signals can be frequency filtered in the frequency range of interest, based on the typical characteristics of the phrenic nerve signal, and then analyzed over time to observe periods or bursts of activity in the frequency range of interest.
  • the processed nerve activity waveforms additionally may be used to determine parameters for nerve stimulation.
  • the processed waveforms may provide information regarding intrinsic breath rate (e.g., if the patient is attempting to breathe on his/her own) and nerve signal amplitude.
  • the stimulation parameters may be adjusted based on the breath rate of previous stimulated breaths (e.g., to increase or decrease the breath rate, as sensed by the sensing electrodes) and nerve activity resulting from stimulation during previous breaths (e.g., to increase or decrease the strength of stimulation).
  • Various parameters that may be adjusted include stimulation pulse amplitude, stimulation pulse width, stimulation pulse frequency, stimulation duration, and the interval between stimulations/pulse trains (e.g., stimulated breath rate). Accordingly, sensed nerve activity signals may be used to determine and adjust the nerve stimulation parameters in a closed-loop system.
  • Impedance information may be used to determine a breath rate of the patient in order to adjust nerve stimulation parameters (e.g., stimulation pulse amplitude, stimulation pulse width, stimulation pulse frequency, stimulation duration, and the interval between stimulations/pulse trains (e.g., stimulated breath rate)).
  • nerve stimulation parameters e.g., stimulation pulse amplitude, stimulation pulse width, stimulation pulse frequency, stimulation duration, and the interval between stimulations/pulse trains (e.g., stimulated breath rate)
  • Electrical impedance of lung tissue changes as a function of air content. Accordingly, the electrical impedance of the thorax changes during inhalation and exhalation.
  • the thorax presents an electrical impedance that includes two components: a relatively constant value and a varying value.
  • Changes in impedance may result from the following two effects during inspiration: 1) there is an increase in the gas volume of the chest in relation to the fluid volume, which may cause conductivity to decrease, and 2) the length of the conductance path (e.g., between two electrodes) increases when the lungs expand. These effects may cause impedance to increase during inspiration. There is an approximately linear correlation between the impedance changes and the volume of respirated air.
  • the varying component of impedance i.e., respirative impedance
  • This varying voltage component can then be used to determine the person's breathing rate.
  • increasing stimulation pulse amplitude, width and/or frequency may increase lung volume during a stimulated breath.
  • Increasing stimulation duration may increase lung volume and/or increase the amount of time air remains in the lungs during a stimulated breath, allowing for an extended gas exchange period.
  • Increasing the stimulated breath rate may allow for additional gas exchange periods over a given period of time, which may increase the amount and/or speed of gas exchange.
  • system 10 may assist a user in one or more of positioning a transvascular catheter, selecting optimal electrodes for nerve stimulation, or selecting or adjusting parameters for nerve stimulation.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Electrotherapy Devices (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)

Abstract

A method for positioning an intravascular catheter may include inserting the intravascular catheter into a venous system of a patient, wherein the catheter includes a plurality of electrodes, and multiple electrodes of the plurality of electrodes are configured to emit electrical signals; positioning a distal portion of the catheter in a first position; using one or more electrodes of the plurality of electrodes to acquire an ECG signal; based on the acquired ECG signal, adjusting the distal portion of the catheter to a second position different from the first position; identifying at least one first electrode of the plurality of electrodes to stimulate a first nerve; identifying at least one second electrode of the plurality of electrodes to stimulate a second nerve; and stimulating at least one of the first and second nerves to cause a contraction of a respiratory muscle.

Description

    TECHNICAL FIELD
  • This disclosure relates to systems, devices, and methods for one or more of positioning an intravascular nerve stimulation catheter, selecting electrodes for nerve stimulation, or stimulating nerves.
  • BACKGROUND
  • Electrical stimulation of nerves may be used to control muscle activity or to generate or attenuate sensations. Nerves and muscles may be stimulated by placing electrodes in, around, or near the nerves and muscles and by activating the electrodes by means of an implanted or external source of energy (e.g., electricity).
  • The diaphragm muscle provides an important function for the respiration of human beings. The phrenic nerves normally transmit signals from the brain to cause the contractions of the diaphragm muscle necessary for breathing. However, various conditions can prevent appropriate signals from being delivered to the phrenic nerves. These include: permanent or temporary injury or disease affecting the spinal cord or brain stem; Amyotrophic Lateral Sclerosis (ALS); decreased day or night ventilatory drive (e.g., central sleep apnea, Ondine's curse); and decreased ventilatory drive while under the influence of anesthetic agents and/or mechanical ventilation. These conditions affect a significant number of people.
  • Intubation and positive pressure mechanical ventilation (MV) may be used for periods of several hours or several days, sometimes weeks, to help critically ill patients breathe while in intensive care units (ICU). Some patients may be unable to regain voluntary breathing and thus require prolonged or permanent mechanical ventilation. Although mechanical ventilation can be initially lifesaving, it has a range of significant problems and/or side effects. Mechanical ventilation:
      • often causes ventilator-induced lung injury (VILI) and alveolar damage, which can lead to accumulation of fluid in the lungs and increased susceptibility to infection (ventilator-associated pneumonia, VAP);
      • commonly requires sedation to reduce discomfort and anxiety in acutely intubated patients;
      • leads to rapid atrophy of the disused diaphragm muscle (ventilator-induced diaphragm dysfunction, VIDD);
      • can adversely affect venous return because the lungs are pressurized and the diaphragm is inactive;
      • interferes with eating and speaking;
      • requires apparatus that is not readily portable; and
      • increases the risk of dying if the patient fails to regain normal breathing and becomes ventilator-dependent.
  • A patient who is sedated and connected to a mechanical ventilator cannot breathe normally because the central neural drive to the diaphragm and accessory respiratory muscles are suppressed. Inactivity leads to muscle disuse atrophy and an overall decline in well-being. Diaphragm muscle atrophy occurs rapidly and can be a serious problem to the patient. According to a published study of organ donor patients (Levine et al., New England Journal of Medicine, 358: 1327-1335, 2008), after only 18 to 69 hours of mechanical ventilation, all diaphragm muscle fibers had shrunk on average by 52-57%. Muscle fiber atrophy results in muscle weakness and increased fatigability. Therefore, ventilator-induced diaphragm atrophy could cause a patient to become ventilator-dependent. It has been estimated that over 600,000 U.S. patients will be ventilator-dependent and require prolonged mechanical ventilation by the year 2020. Zilberberg et al., “Growth in adult prolonged acute mechanical ventilation: implications for healthcare delivery,” Crit Care Med., 2008 May, 36(5): 1451-55.
  • SUMMARY
  • Embodiments of the present disclosure relate to, among other things, systems, devices, and methods for one or more of positioning an intravascular nerve stimulation catheter, selecting electrodes for nerve stimulation, or stimulating nerves. Each of the embodiments disclosed herein may include one or more of the features described in connection with any of the other disclosed embodiments.
  • In one example, a method for positioning an intravascular catheter may include inserting the intravascular catheter into a venous system of a patient, wherein the catheter includes a plurality of electrodes, and multiple electrodes of the plurality of electrodes are configured to emit electrical signals; positioning a distal portion of the catheter in a first position; using one or more electrodes of the plurality of electrodes to acquire an ECG signal; based on the acquired ECG signal, adjusting the distal portion of the catheter to a second position different from the first position; identifying at least one first electrode of the plurality of electrodes to stimulate a first nerve; identifying at least one second electrode of the plurality of electrodes to stimulate a second nerve; and stimulating at least one of the first and second nerves to cause a contraction of a respiratory muscle.
  • Any method described herein may additionally or alternatively include one or more of the following features or steps: inserting the intravascular catheter into the venous system may include inserting the intravascular catheter into: 1) at least one of a left subclavian, axillary, cephalic, cardiophrenic, brachial, radial, or left jugular vein, and 2) a superior vena cava; the first position may be proximate an atrium of a heart of the patient, and the second position may be in a superior vena cava; the ECG signal may be a first ECG signal, and the method may further comprise using one or more electrodes of the plurality of electrodes to acquire a second ECG signal; the one or more electrodes used to acquire the first ECG signal may be positioned on a proximal portion of the catheter and may be configured to stimulate the first nerve, and the one or more electrodes used to acquire the second ECG signal may be positioned on a distal portion of the catheter and may be configured to stimulate the second nerve; the method may further include comparing the first ECG signal to the second ECG signal, and based on the comparison, adjusting the distal portion of the catheter to the second position; the second position may be farther from a heart of the patient than the first position; the method may further include using one or more electrodes of the plurality of electrodes to sense at least one of an impedance or nerve activity; or each of the at least one first electrode and the at least one second electrode may be a combination of electrodes.
  • In another example, a method for positioning an intravascular catheter may include inserting the intravascular catheter into: 1) at least one of a left subclavian vein or a left jugular vein, and 2) a superior vena cava, wherein the catheter includes a plurality of electrodes, and the plurality of electrodes includes a proximal set of electrodes positioned proximate a left phrenic nerve and a distal set of electrodes positioned proximate a right phrenic nerve; using one or more electrodes of the plurality of electrodes to acquire an ECG signal; based on a change in the ECG signal, withdrawing the catheter away from a heart of a patient; stimulating the left phrenic nerve using one or more electrodes of the proximal set of electrodes; and stimulating the right phrenic nerve using one or more electrodes of the distal set of electrodes.
  • Any method described herein may additionally or alternatively include one or more of the following features or steps: the change in the ECG signal may be a change in an amplitude of a P-wave, and the change may occur as a distal end of the catheter enters a region proximate an atrium of the heart; the step of withdrawing the catheter away from the heart may cause a change in the amplitude of the P-wave; the ECG signal may be a first ECG signal acquired by one or more electrodes of the proximal set of electrodes, and the method may further include using one or more electrodes of the distal set of electrodes to acquire a second ECG signal; the method may further include determining a difference between a P-wave of the first ECG signal and a P-wave of the second ECG signal, and withdrawing the catheter away from the heart of the patient when the difference exceeds a predetermined value; the difference may exceed the predetermined value when the catheter is advanced into an atrium of the heart; a hub coupled to the catheter and positioned exterior to the patient may be used with the one or more electrodes of the plurality of electrodes to acquire the ECG signal; or the method may further include monitoring the ECG signal as a distal end of the catheter is inserted into the at least one of the left subclavian vein or the left jugular vein and advanced into the superior vena cava.
  • In yet another example, a method for positioning an intravascular catheter may include inserting the intravascular catheter into a venous system of a patient, wherein the catheter includes a plurality of proximal electrodes and a plurality of distal electrodes; using one or more electrodes of the plurality of proximal electrodes to acquire a first ECG signal, and using one or more electrodes of the plurality of distal electrodes to acquire a second ECG signal; comparing the first ECG signal to the second ECG signal; based on the comparison between the first ECG signal and the second ECG signal, adjusting a position of the catheter; stimulating the first nerve using one or more of the plurality of proximal electrodes; and stimulating the second nerve using one or more of the plurality of distal electrodes.
  • Any method described herein may additionally or alternatively include one or more of the following features or steps: the first nerve may be a left phrenic nerve, and the second nerve may be a right phrenic nerve; comparing the first ECG signal to the second ECG signal may include comparing an amplitude of a portion of the first ECG signal to an amplitude of a portion of the second ECG signal; the step of comparing may occur a plurality of times during the inserting step; adjusting the position of the catheter may include moving the catheter away from a heart; at least one of stimulating the first nerve or stimulating the second nerve may cause a contraction of a diaphragm; or the method may further include sensing activity of the first nerve using one or more of the proximal electrodes and sensing activity of the second nerve using one or more of the distal electrodes
  • In another example, a method for positioning an intravascular catheter may include inserting the intravascular catheter into: 1) at least one of a left subclavian vein or a left jugular vein, and 2) a superior vena cava, wherein the catheter includes a plurality of proximal electrodes configured to be positioned proximate a left phrenic nerve and a plurality of distal electrodes configured to be positioned proximate a right phrenic nerve; at multiple positions of the catheter during the inserting step, using one or more electrodes of the plurality of proximal electrodes to acquire a first ECG signal, and using one or more electrodes of the plurality of distal electrodes to acquire a second ECG signal; comparing the first ECG signal to the second ECG signal at several of the multiple positions; based on the comparisons of the first ECG signal to the second ECG signal, determining a desired position of the catheter for nerve stimulation; stimulating the left phrenic nerve using one or more of the plurality of proximal electrodes; and stimulating the right phrenic nerve using one of more of the plurality of distal electrodes.
  • Any method described herein may additionally or alternatively include one or more of the following features or steps: the method may further include advancing a distal end of the catheter into a region proximate an atrium of a heart; one of the multiple positions may be a position in which the distal end of the catheter is proximate the atrium of the heart, and in the position, the comparison may indicate a difference between an amplitude of the first ECG signal and an amplitude of the second ECG signal that exceeds a predetermined value; the method may further include moving the catheter away from the heart; stimulating the left phrenic nerve may cause a diaphragm contraction, and stimulating the right phrenic nerve may cause a diaphragm contraction; the proximal electrodes used to acquire the first ECG signal may be configured to stimulate the left phrenic nerve, and the distal electrodes used to acquire the second ECG signal may be configured to stimulate the right phrenic nerve.
  • It may be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the invention, as claimed. As used herein, the terms “comprises,” “comprising,” or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements, but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. The term “exemplary” is used in the sense of “example,” rather than “ideal.”
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate exemplary embodiments of the present disclosure and together with the description, serve to explain the principles of the disclosure.
  • FIG. 1 illustrates a nerve stimulation system with an intravascular catheter positioned within a patient, according to an exemplary embodiment.
  • FIG. 2 illustrates a nerve stimulation system having a portable control unit, according to an exemplary embodiment.
  • FIG. 3 illustrates a wireless configuration of a nerve stimulation system, according to an exemplary embodiment.
  • FIG. 4 illustrates an intravascular catheter having a helical portion, according to an exemplary embodiment.
  • FIG. 5 illustrates an intravascular catheter having an optical fiber camera, according to an exemplary embodiment.
  • FIG. 6 illustrates an intravascular catheter having an ultrasound transducer, according to an exemplary embodiment.
  • FIG. 7 illustrates a block diagram of a nerve stimulation system having an intravascular catheter and a control unit, according to an exemplary embodiment.
  • DETAILED DESCRIPTION
  • When electrically stimulating nerves or muscles, a variety of goals may be considered. First, it may be desirable to place the electrodes in proximity to the phrenic nerves. Second, it may be desirable to avoid placing electrodes in close proximity to the sinoatrial (SA) node, atrioventricular (AV) node, or the His-Purkinje system located in heart tissue, as electrical stimulation of these anatomical features may cause arrhythmia. Third, when using a device that includes multiple electrodes, it may be desirable to identify particular electrodes that are in close proximity to the nerve. Identifying the proper electrodes may minimize the electrical charge required to effectively stimulate the nerves. Finally, as with any medical procedure, the risk of injury to the patient increases with the length and complexity of the medical procedure. Accordingly, it may be desirable to minimize the length of any procedure to electrically stimulate nerves or muscles.
  • There remains a need for cost-effective, practical, surgically simple, and minimally invasive devices and methods that address one or more of the above goals and can include one or more of a variety of functions, including: determining whether a nerve is the target nerve, stimulating breathing, delivering treatment (e.g., medications), sensing electrical signals from the body (e.g., ECG), sensing internal vascular blood pressure, heart rate, and electrical impedance, and performing tests, such as detecting respiration rate and blood gas levels (e.g, CO2, O2). There is also a need for devices and methods to help patients wean from mechanical ventilation and regain the ability to breathe naturally.
  • Accordingly, the present disclosure is drawn to systems, devices, and methods for one or more of positioning an intravascular catheter for nerve stimulation, selecting electrodes for nerve stimulation, and stimulating nerves. In particular, embodiments of the present disclosure may use various positioning features to obtain information useful for positioning a transvascular nerve stimulation catheter, or may use information gathered by sensors to select electrodes and parameters for nerve stimulation.
  • General System Overview
  • FIG. 1 illustrates a system 10 that includes a transvascular nerve stimulation catheter 12 and a control unit 14. Catheter 12 may include a plurality of electrodes 34. Catheter 12 may be operably connected (e.g., hardwired, wireless, etc.) to a control unit 14. The control unit 14 may be programmed to perform any of the functions described herein in connection with system 10. In some embodiments, the control unit 14 may include a remote controller 16 to allow a patient or health professional to control operation of the control unit 14 at a distance from the control unit 14. The controller 16 may include a handheld device, as illustrated in FIG. 1. In some examples, controller 16 may include a footswitch/pedal, a voice-activated, touch-activated, or pressure-activated switch, or any other form of a remote actuator. The control unit 14 may include a touch screen 18 and may be supported by a cart 20.
  • During use, a proximal portion of catheter 12 may be positioned in a left subclavian vein 22, and a distal portion of catheter 12 may be positioned in a superior vena cava 24. Positioned in this manner, electrodes 34 on the proximal portion of catheter 12 may be positioned proximate a left phrenic nerve 26, and electrodes 34 on the distal portion of catheter 12 may be positioned proximate a right phrenic nerve 28. Left and right phrenic nerves 26, 28 may innervate a diaphragm 30. Accordingly, catheter 12 may be positioned to electrically stimulate one or both of the left and right phrenic nerves 26, 28 to cause contraction of the diaphragm muscle 30 to initiate or support a patient breath. In other embodiments, the proximal portion of catheter 12 may be positioned in a left jugular vein 32, and the distal portion of catheter 12 may be positioned in superior vena cava 24.
  • In further examples, catheter 12 can be placed into and advanced through other vessels providing access to the locations adjacent the target nerve(s) (e.g., phrenic nerves), such as: the jugular, axillary, cephalic, cardiophrenic, brachial, or radial veins. In addition, catheter 12 may use other forms of stimulation energy, such as ultrasound, to activate the target nerves. In some examples, the system 10 can target other respiratory muscles (e.g., intercostal) either in addition to, or alternatively to, the diaphragm 30. The energy can be delivered via one or more methods including transvascular, subcutaneous, nerve cuffs, transdermal stimulation, or other techniques known in the field.
  • FIG. 2 illustrates an alternative example of system 10, in which control unit 14′ is portable. Portable control unit 14′ may include all of the functionality of control unit 14 of FIG. 1, but it may be carried by a patient or other user to provide the patient with more mobility. In addition to carrying the control unit 14′, the patient can wear control unit 14′ on a belt, on other articles of clothing, or around his/her neck, for example. In other examples, control unit 14′ may be mounted to a patient's bed to minimize the footprint of system 10 in the area around the patient, or to provide portable muscle stimulation in the event a bed-ridden patient needs to be transported or moved to another location.
  • Similar to FIG. 1, the system of FIG. 2 may include a controller 16, shown as a handheld controller 16. Handheld controller 16 may include buttons 17, 19 that can be pressed by a patient or other user to control breathing patterns. In one example, pressing one of buttons 17, 19 can initiate a “sigh” breath, which may cause a greater volume of air to enter the patient's lungs than in a previous breath. A sigh breath may result when electrodes 34 of catheter 12 are directed to stimulate one or more of the phrenic nerves 26, 28 at a higher level than a normal breath (i.e., a stimulation train having a longer duration of stimulation or having pulses with a higher amplitude, pulse width, or frequency). Higher amplitude stimulation pulses can recruit additional nerve fibers, which in turn can engage additional muscle fibers to cause stronger and/or deeper muscle contractions. Extended pulse widths or extended durations of the stimulation train can deliver stimulation over longer periods of time to extend the duration of the muscle contractions. In the case of diaphragm muscle stimulation, longer pulse widths have the potential to help expand the lower lung lobes by providing greater or extended negative pressure around the outside of the lungs. Such negative pressure has the potential to help prevent or mitigate a form of low pressure lung injury known as atelectasis. The increased stimulation of the one or more phrenic nerves 26, 28 may result in a more forceful contraction of the diaphragm 30, causing the patient to inhale a greater volume of air, thereby providing a greater amount of oxygen to the patient. Sigh breaths may increase patient comfort.
  • In other examples, buttons 17, 19 may allow the patient or other user to start and stop stimulation therapy, or to increase or decrease stimulation parameters, including stimulation charge (amplitude×pulse width), frequency of pulses in a stimulation train, or breath rate. LED indicators or a small LCD screen (not shown) on the controller may provide other information to guide or inform the operator regarding the stimulation parameters, the feedback from the system sensors, or the condition of the patient.
  • FIG. 3 illustrates another example of system 10 in which a control unit 14″ is implanted in the patient, along with catheter 12. System 10 may further include remote controller 16 and a programmer 98 that communicates with control unit 14″ wirelessly. In this embodiment, each of programmer 98, control unit 14″, and remote controller 16 may include a wireless transceiver 92, 94, 96, respectively, so that each of the three components can communicate wirelessly with each other. Control unit 14″ may include all of the electronics, software, and functioning logic necessary to perform the functions described herein. Implanting control unit 14″ as shown in FIG. 3 may allow catheter 12 to function as a permanent breathing pacemaker. Programmer 98 may allow the patient or health professional to modify or otherwise program the nerve stimulation or sensing parameters. Remote controller 16 may be used as described in connection with FIGS. 1 and 2. In other examples, remote controller 16 may be in the form of a smartphone, tablet, watch or other wearable device.
  • Catheter Features
  • Referring to FIGS. 1-3, catheter 12 may include a stimulation array comprising a plurality of electrodes 34 or other energy delivery elements. In one example, electrodes 34 may be surface electrodes located on an outer wall of catheter 12. In another example, electrodes 34 may be positioned radially inward relative to the outer wall of catheter 12 (e.g., exposed through openings in the outer wall). In yet another example, the electrodes 34 may include printed electrodes as described in U.S. Pat. No. 9,242,088, which is incorporated by reference herein (see below).
  • Electrodes 34 may extend partially around the circumference of catheter 12. This “partial” electrode configuration may allow electrodes 34 to target a desired nerve for stimulation, while minimizing application of electrical charge to undesired areas of the patient's anatomy (e.g., other nerves or the heart). As shown in FIG. 1, catheter 12 may include a proximal set 35 of electrodes 34 configured to be positioned proximate to and stimulate left phrenic nerve 26 and a distal set 37 of electrodes 34 configured to be positioned proximate to and stimulate right phrenic nerve 28. As shown in FIG. 5, electrodes 34 may be arranged in rows extending along the length of catheter 12. In one example, proximal set 35 may include two rows, and distal set 37 may include two rows.
  • Furthermore, the catheters described herein may include any features of the nerve stimulation devices described in the following documents, which are all incorporated by reference herein in their entireties: U.S. Pat. No. 8,571,662 (titled “Transvascular Nerve Stimulation Apparatus and Methods,” issued Oct. 29, 2013); U.S. Pat. No. 9,242,088 (titled “Apparatus and Methods for Assisted Breathing by Transvascular Nerve Stimulation,” issued Jan. 26, 2016); U.S. Pat. No. 9,333,363 (titled “Systems and Related Methods for Optimization of Multi-Electrode Nerve Pacing,” issued May 10, 2016); U.S. application Ser. No. 14/383,285 (titled “Transvascular Nerve Stimulation Apparatus and Methods,” filed Sep. 5, 2014); or U.S. application Ser. No. 14/410,022 (titled “Transvascular Diaphragm Pacing Systems and Methods of Use,” filed Dec. 19, 2014). In addition, the control units described herein can have any of the functionality of the control units described in the above-referenced patent documents (e.g., the control units described herein can implement the methods of nerve stimulation described in the incorporated documents).
  • During nerve stimulation, one or more electrodes 34 may be selected from the proximal set 35 for stimulation of left phrenic nerve 26, and one or more electrodes 34 may be selected from the distal set 37 for stimulation of right phrenic nerve 28. Catheter 12 may stimulate nerves using monopolar, bipolar, or tripolar electrode combinations, or using any other suitable combination of electrodes 34. In some examples, a second or third stimulation array can be used to stimulate other respiratory muscles. When multiple nerves or muscles are being stimulated, the controller and sensors described herein may be used to coordinate stimulation to achieve the desired muscle activation, breath, or level of respiratory support.
  • Catheter 12 may further include one or more lumens. Each lumen may extend from a proximal end of catheter 12 to a distal end of catheter 12, or to a location proximate the distal end of catheter 12. The lumens may contain medical devices, such as a guidewire or an optical fiber camera. Furthermore, the one or more lumens may be used for any suitable purpose, such as drawing blood samples or providing a pathway for delivering medications into the patient. In some examples, lumens may contain or be fluidly connected to sensors, such as blood gas sensors or pressure sensors.
  • In this disclosure, the figures illustrating catheter 12 may each illustrate different features and different combinations of features. However, catheter 12 may include any combination of the features that are described herein. Accordingly, the features of catheter 12 are not limited to the specific combinations shown in the various figures.
  • Referring to FIG. 2, a hub 36 may be connected to the proximal end of catheter 12. Hub 36 may include a conductive surface and can act as a reference electrode during monopolar stimulation or sensing. In some embodiments, hub 36 may be sutured on a patient's skin. In addition, hub 36 may be used as an ECG electrode.
  • FIG. 4 illustrates catheter 12 inserted into left jugular vein 32 and superior vena cava 24. As described above, catheter 12 includes a plurality of electrodes 34, with proximal electrodes 34 positioned near left phrenic nerve 26 and distal electrodes 34 positioned near right phrenic nerve 28. Catheter 12 may further include three lumens (not shown) that connect with extension lumens 38, 40, 42 that extend proximally from hub 36. The distal portion of catheter 12 may be configured to assume a helical shape 44 when positioned within the patient. Helical shape 44 may help anchor catheter 12 to the vessel wall to stabilize catheter 12 during nerve stimulation. Furthermore, helical shape 44 may allow electrodes 34 to be positioned at different radial positions within the vessel, which may be useful when selecting electrodes for nerve stimulation. For example, in certain instances it may be desirable to stimulate the nerve with electrodes 34 that are closer to the nerve (e.g., to obtain a stronger diaphragm response), and in other instances it may be desirable to stimulate the nerve with electrodes 34 that are farther away from the nerve (e.g., to obtain a weaker diaphragm response, or prevent stimulation of the vagus nerve).
  • In one example, helical shape 44 may be obtained by using a stiffening wire inserted into a lumen of catheter 12 via an extension lumen 38, 40, or 42. The stiffening wire may include a shape-memory material (e.g., Nitinol) biased to a helical shape, stainless steel, or any other suitable material. The portion of catheter 12 configured to assume the helical shape 44 may include materials having a lower stiffness than other portions of catheter 12. For example, the materials along helical shape 44 may be thinner or more flexible than the materials along the remaining length of catheter 12. In another example, catheter 12 may include a temperature-activated shape memory material (e.g., Nitinol) along a portion of its length, such that the shape-memory material of catheter 12 may have a substantially straight shape at room temperature and may assume a helical shape when heated within the patient's body.
  • In some examples, the proximal portion of catheter 12 additionally or alternatively may have a feature, similar to the distal portion of catheter 12, to allow it to assume a helical shape when positioned within left jugular vein 32 (or left subclavian vein 22). Any proximal helical shape may be obtained or result from any of the features described in connection with helical shape 44. If both the proximal and distal portions of catheter 12 assume a helical shape when positioned within the patient, both the proximal and distal electrodes 34 may be fixed relative to the left and right phrenic nerves 26, 28, respectively. To account for body movements when the patient breathes or moves, catheter 12 may further include a helical shape along a central portion of catheter 12. In one example, the diameter of an expanded helical shape in the central portion may be less than the diameter of the vessel wall, so that the central helical shape is not fixed relative to the vessel wall. Accordingly, the central helical portion may allow catheter 12 to freely expand and contract in length within the vessel as body movements cause the distance between the proximal helix and the distal helix (which may be fixed relative to the vessel walls) to vary. The central helical shape may be obtained or result from any of the features described in connection with helical shape 44.
  • Referring to FIG. 5, each of the extension lumens 38, 40, and 42 may end in a proximal-most port 38 a, 40 a, and 42 a, respectively. Further, the lumens internal to catheter 12 may terminate in one or more distal ports. In one example, internal lumens that communicate with lumens 38, 40, and 42 terminate at a distal port 48, medial port 50, and proximal port 52, respectively. Lumens 38, 40, 42 and their corresponding internal lumens may be used to transport fluid to and from the patient, such as to deliver medications or withdraw blood or other bodily fluids. In other examples, these lumens may be used to hold a guidewire, stiffening wire, optical fiber camera, sensors, or other medical devices. FIG. 5 illustrates an optical fiber camera 46 inserted into lumen 38, extending through a corresponding internal lumen, and exiting from distal port 48.
  • FIG. 6 illustrates another example of catheter 12. Catheter 12 is similar to the catheter of FIG. 5, except electrodes 34 may be formed by conductive inks (such as silver, gold, graphine, or carbon flakes suspended in polymer or other media) printed on the surface of catheter 12, as described in U.S. Pat. No. 9,242,088, incorporated by reference herein (see above). These conductive inks may be deposited and adhered directly onto catheter 12 and sealed, except for the exposed electrodes 34, with an outer polyurethane or other flexible insulative film. The exposed electrodes 34 may be coated (e.g., with titanium nitride) for purposes such as one or more of: enhancing electrical properties, such as conductivity and surface area; providing corrosion resistance; and reducing the potential for formation of silver oxide, which could be toxic. As can be seen in FIG. 6, the conductive ink trace of distal electrodes may travel proximally along catheter 12 past the more proximal electrodes 34. FIG. 6 further illustrates catheter 12 having an ultrasound transducer 54 at a distal end of catheter 12, which will be described further below.
  • Detailed System Components
  • FIG. 7 illustrates a block diagram of the various components of system 10. The electrodes 34 a-34 j, hub 36, and lumens 38, 40, 42, 58, and 60 may be part of catheter 12 described herein. Catheter 12 may have any number of electrodes and any number of lumens. Five lumens are illustrated in FIG. 7, but in different examples, the catheter may include one, two, three, four, or more than five lumens. In one example, catheter 12 may have three lumens (e.g., extension lumens 38, 40, 42 and corresponding internal lumens), which each may hold one or more of a guidewire or optical fiber camera, or may be used for fluid delivery or blood sample extraction (box 43). In another example, catheter 12 may include four lumens, with one lumen 58 holding or fluidly connected to a pressure sensor 90, one lumen 60 holding or fluidly connected to a blood gas sensor 62, and the other two lumens holding a guidewire or optical fiber camera and/or being used for fluid delivery or blood sample extraction. It should be understood that any lumen of system 10 may contain or be fluidly connected to any of the devices (e.g., sensors, guidewire, optical fiber camera) described herein and/or may be used for any of the functions described herein (e.g., fluid delivery, blood sample extraction).
  • System 10 may include a controller 64, which may be part of any of the control units described herein. Each of the components of system 10 may be operably coupled to the controller 64, and controller 64 may manage operation of electrodes 34 during nerve stimulation, control the gathering of information by various sensors and electrodes 34, and control fluid delivery or extraction. It should be understood that the various modules described herein may be part of a computing system and are separated in FIG. 7 for explanatory purposes only; it is not necessary for the modules to be physically separate.
  • Electrodes 34 a-34 j may be electronically coupled to switching electronics 56, which may be communicably coupled to controller 64. As shown in FIG. 7, a portion of electrodes 34 may be distal electrodes 34 a-34 d, and a portion of electrodes 34 may be proximal electrodes 34 g-34 j. Other electrodes 34, such as electrodes 34 e and 34 f, may be positioned between the proximal and distal electrodes and, depending on the placement of catheter 12, may be used for stimulating either left or right phrenic nerves 26, 28. Hub 36 also may be connected to switching electronics 56 and may be used as an electrode.
  • Electrodes 34 a-34 j may be used for both electrically stimulating nerves and for gathering physiological information. When being used for nerve stimulation, a first combination of electrodes (e.g., one, two, three, or more electrodes) may be electrically coupled to a first stimulation module channel 70 for stimulation of a first nerve (e.g., the right phrenic nerve) and a second combination of electrodes (e.g., one, two, three, or more electrodes) may be electrically coupled to a second stimulation module channel 72 for stimulation of a second nerve (e.g., the left phrenic nerve). Electrical signals may be sent from the first and second stimulation module channels 70, 72 to the electrode combinations to cause the electrodes to stimulate the nerves. In other examples, more than two electrode combinations (e.g., 3, 4, or more) may be used to stimulate one or more target nerves, and system 10 may include more than two stimulation module channels.
  • Electrodes 34 a-34 f may be further configured to sense physiological information from a patient, such as nerve activity, ECG, or electrical impedance, as will be described further below. When being used for sensing, one or more of electrodes 34 a-34 f may be electronically coupled to a signal acquisition module 68. Signal acquisition module 68 may receive signals from electrodes 34.
  • Switching electronics 56 may selectively couple electrodes 34 to first stimulation module channel 70, second stimulation module channel 72, or signal acquisition module 68. For example, if an electrode 34 (e.g., electrode 34 a) is being used to acquire a signal, such as an ECG signal, that electrode 34 may be coupled via switching electronics 56 to signal acquisition module 68. Similarly, if a pair of electrodes (e.g., electrodes 34 b and 34 d) is being used to stimulate right phrenic nerve 28, those electrodes may be coupled via switching electronics 56 to first stimulation module channel 70. Finally, if a pair of electrodes (e.g., electrodes 34 g and 34 h) is being used to stimulate left phrenic nerve 26, those electrodes may be coupled via switching electronics 56 to second stimulation module channel 72. Switching electronics 56 may change which electrodes 34 are used for stimulation and which are used for sensing at any given time. In one example, any electrode 34 can be used for nerve stimulation and any electrode 34 can be used for sensing functions described herein. In other words, each electrode 34 may be configured to stimulate nerves, and each electrode 34 may be configured to sense physiological information.
  • Signal acquisition module 68 may further be coupled to one or more sensors configured to gather physiological information from a patient. For example, system 10 may include one or more of blood gas sensor 62 or pressure sensor 90. These sensors may be located in lumens of catheter 12, outside of the patient in fluid communication with a lumen, on an outer surface of catheter 12, or in any other suitable location. In one example, blood gas sensor 62 may be housed in or fluidly connected to lumen 60, while pressure sensor 90 may be housed in or fluidly connected to lumen 58. Blood gas sensor 62 may measure the amount of O2 or CO2 in the patient's blood. Pressure sensor 90 may measure the central venous pressure (CVP) of the patient.
  • Signal acquisition module 68 may transmit the signals received from one or more of electrodes 34, blood gas sensor 62, and/or pressure sensor 90 to the appropriate processing/filtering module of system 10. For example, signals from pressure sensor 90 may be transmitted to a central venous pressure signal processing/filtering module 84, where the signals are processed and filtered to aid in interpretation of CVP information. Similarly, signals from blood gas sensor 62 may be transmitted to a blood gas signal processing/filtering module 86 for processing and filtering to determine blood gas levels. Signals from electrodes 34, when they are used for sensing, may be sent to nerve signal processing/filtering module 80, ECG signal processing/filtering module 82, or impedance signal processing/filtering module 88, as appropriate. Signals from electrodes 34 or other sensors may be sent to amplification module 78, if necessary, to amplify the signals prior to being sent to the appropriate processing/filtering module.
  • Controller 64 may further communicate with display 74, which may serve as a user interface and may have a touch screen 18 (see FIG. 1). System 10 may further include software/firmware 76, which may contain the instructions necessary for carrying out the various functions described herein. Finally, system 10 may include data storage 79, for storing information gathered during sensing operations of catheter 12, and/or for storing instructions related to the operation of any of the modules or instructions for carrying out any of the functions described herein. Catheter 12 may contain unique identification features (e.g., RFID), and in the event the system 10 described herein (e.g., having one or more of controllers/ programmers 14, 14′, 14″, 98, 64) is used to treat multiple patients concurrently, the catheter identification feature may allow the system 10 to uniquely identify each patient and access that patient's stored patient data.
  • Catheter Positioning
  • Catheter 12 may include a variety of positioning features that may help a user to position catheter 12 within a patient. Some positioning features may be visualization aids, such as optical fiber camera 46 shown in FIG. 5 or ultrasound transducer 54 shown in FIG. 6. Other positioning features may be sensors to sense physiological parameters, such as pressure sensor 90. Electrodes 34, which can be used to stimulate a nerve, also may be used as sensors to gather information that can then be used to position catheter 12. For example, electrodes 34 may gather information related to nerve activity (e.g., the left or right phrenic nerve), ECG signals, and/or impedance. Accordingly, a sensing electrode 34 may be considered a positioning feature. Each of the positioning features and how they are used to help position catheter 12 will be described in further detail below.
  • Catheter 12 may include any combination of positioning features, including one or more visualization aids, sensors (e.g., pressure), or electrodes capable of sensing various types of information. Similarly, the control units described herein, whether on a cart, wearable on a patient, or wireless, may be configured to process information gathered by the various positioning features described herein (e.g., visualization aids, sensors, and electrodes), as well as perform the various computerized functions described herein.
  • Referring back to FIG. 5, optical fiber camera 46 may be positioned within extension lumen 38 and its corresponding internal lumen within catheter 12, either temporarily or as an integral, permanent component of catheter 12. It should be understood that optical fiber camera 46 could be inserted into any of the extension lumens 38, 40, 42 and internal lumens, and could exit any of the ports 48, 50, 52. Optical fiber camera 46 may be used to aid in positioning of catheter 12 within the patient. For example, images from optical fiber camera 46 may be transmitted in real time to a health professional or other user during a procedure, who may rely on the images to guide catheter 12 through the patient's vessels and/or to adjust the position of the catheter within the vessels.
  • Referring back to FIG. 6, ultrasound transducer 54 may be used in addition to or instead of optical fiber camera 46 to obtain information useful for positioning catheter 12 within the patient. Ultrasound transducer 54 may be secured temporarily or permanently to the exterior of catheter 12, as shown in FIG. 6, or may be positioned temporarily or permanently within a lumen of catheter 12 (e.g., positioned to extend from the distal end of a lumen of catheter 12). Positioning ultrasound transducer 54 near the distal tip of catheter 12 may allow the user to view the inside of vessels and also ensure that the tip of catheter 12 is not positioned in an undesired location (e.g., in the atrium of the heart). For example, ultrasound transducer 54 may allow visualization of a heart valve, which could indicate that the catheter 12 has entered the atrium and may need to be retracted.
  • In addition to allowing a user to see the inside of the patient's vessels, the ultrasound images may provide information (e.g., calculated or visual) about the diameter of blood vessels and/or blood flow within the vessels. The user may then use vessel diameter information, blood flow, and real time images of the inside of the patient's vessels to position catheter 12 in a desired position.
  • CVP measurements from pressure sensor 90 may further aid in positioning catheter 12 within the patient. Normal values may vary between 4-12 cm H2O. The CVP waveform may change based on the location, relative to the patient's heart, of the port (e.g., 46, 48, or 50) in communication with pressure sensor 90. In one example, CVP measurements may decline as the relevant port approaches the patient's heart. A user may read the changing CVP waveforms to help position the catheter 12 in a desired location relative to the patient's heart.
  • The CVP waveform has several components. The (a) wave corresponds to the right atrial contraction and correlates with the P wave on the ECG. The (c) wave corresponds to the cusp of the tricuspid valve protruding backwards through the atrium, as the right ventricle begins to contract. The (c) wave correlates with the end of the QRS complex on the ECG. The (x) descent corresponds to the movement of the right ventricle, which descends as it contracts. The downward movement decreases the pressure in the right atrium. At this stage, there is also atrial diastolic relaxation, which further decreases the right atrial pressure. The (x) descent happens before the T wave on the ECG. The (v) wave occurs as blood fills the right atrium and hits the tricuspid valve, causing a back-pressure wave. The (v) wave occurs after the T wave of the ECG. The (y) descent is a pressure decrease caused by the tricuspid valve opening in early ventricular diastole and occurs before the P wave of the ECG. The amplitudes of a, c, x, v, y may change depending on the position of the catheter with respect to the heart. The signature change of the CVP waveform can guide in the placement of catheter 12.
  • In one example, a method for positioning intravascular catheter 12 may include positioning catheter 12 in a first position in a venous system of a patient, wherein catheter 12 includes a plurality of electrodes 34 and at least one lumen extending from a proximal end of catheter 12 to a distal end of catheter 12, and each electrode 34 of the plurality of electrodes 34 is configured to emit electrical signals to stimulate a nerve; measuring a central venous pressure of the patient using a pressure sensor 90 fluidly connected to the at least one lumen; and based on the central venous pressure, adjusting catheter 12 to a second position different from the first position.
  • Nerve signals acquired by electrodes 34 also may be used to aid in positioning catheter 12 within a patient. The electrical signal from a nerve may be amplified by amplification module 78 and processed by nerve signal processing/filtering module 80. The amplified and filtered signals from one or more electrodes 34 then may be compared to an expected signal from the targeted nerve (e.g., left or right phrenic nerve) to identify electrodes 34 in close proximity to the target nerve and to identify the optimal one or more electrodes for nerve stimulation. For example, electrodes 34 returning a higher strength and/or higher quality signal may be located closer to the target nerve.
  • More specifically, phrenic nerve activity can be recorded using bipolar or monopolar electrodes. Phrenic nerve discharge can be amplified and filtered (e.g., 100 Hz to 5 kHz), and a moving average can be obtained using a third-order Paynter filter with a 20 or 50 ms time constant. Phrenic nerve discharge also can be filtered at 10 Hz to 5 kHz for analysis of spectral composition. A sampling rate of 1-10 kHz can be used to capture the nerve activity.
  • The parameters acquired during nerve activity sensing can be used to detect if the signal is from the phrenic nerve or another nerve. Sensed parameters can include a number of physiological parameters, such as amplitude, inspiration duration, and/or breathing rate. For example, if the sensed amplitude shows proximity of the electrodes 34 to the nerve and the nerve is a phrenic nerve, the duration of pulses in a train should match the sensed inspiration duration, and the frequency of the trains should match the sensed breathing rate. Furthermore, the sensed signals from a nerve can be compared to known nerve signatures (e.g., of phrenic nerves) to confirm that the nerve signal is from the desired nerve.
  • Electrodes 34 (e.g., two or three) may be used to acquire ECG signals, with hub 36 optionally being used as a reference electrode. The ECG signal (e.g., morphology, amplitudes, and spectral content) may vary depending on the location, relative to the patient's heart, of the electrodes being used to measure the signal. Monitoring changes in the ECG signal as catheter 12 is being positioned may aid in identifying desired or undesired placement. For example, it may be undesired for catheter 12 to be placed in the atrium of the patient's heart.
  • In one example, one of the distal electrodes 34 on catheter 12 may be designated as a probe. Other electrodes along the length of catheter 12, and in some cases in contact with the skin of the patient, may be used to detect an ECG signal, which can optionally be displayed by control unit 14 via screen 18. Catheter 12 may be advanced through superior vena cava 24 towards the heart. As catheter 12 enters a region proximate the right atrium, or enters the right atrium, the P-wave portion of the ECG may become elevated and create an augmented peaked P-wave, indicating that the tip of the catheter 12 lies in or very close to the right atrium. The operator can observe the change in P-wave, or the control unit 14 can utilize an algorithm to detect the change and provide a visual, audible or other signal to the operator. For example, an LED on catheter hub 36, control unit 14, or remote controller 16 can change from green to yellow and then to red as the P-wave changes indicate that the catheter 12 is approaching and then is positioned within the right atrium. The catheter 12 can then be withdrawn slowly until the P-wave starts to diminish. The catheter 12 can then be withdrawn a further 1-2 cm, thereby positioning the catheter tip in the distal portion of superior vena cava 24.
  • In this example, the positive deflection in the P-wave occurs when current flows to the probing electrode, and a negative deflection when it flows away. The P-wave depolarizes down the right atrium from the SA node, away from an electrode 34 in superior vena cava 24, and is therefore negative. The amplitude of the P-wave is related to the inverse square rule, whereby the amplitude is inversely proportional to the square of the distance from the current source. Thus, the P-wave increases greatly in negative amplitude as catheter 12 approaches the atrium. When the tip enters the atrium, it is just beyond the SA node, and the first portion of the P-wave depolarizes towards it. This results in a brief, small positive deflection followed instantly by a deep negative deflection.
  • Alternatively, a distal combination of electrodes 34 (e.g., a distal pair) and a proximal combinations of electrodes 34 (e.g., a proximal pair) can be used to obtain, respectively, a distal and proximal ECG signal having a P-wave. The P-waves can be compared using standard signal processing techniques and a delta value can be determined as the catheter 12 is advanced through the vessel (e.g. superior vena cava 24) towards the heart. As catheter 12 is advanced in close proximity to or into the atrium, the delta value will change significantly, exceeding a predetermined value. The system 10 can provide an indicator to the operator, as described previously, and catheter 12 can be withdrawn 1 to 2 cm. This method can also utilize one or more reference electrodes 34 located along the length of the catheter or positioned externally on the patient's body.
  • Electrodes 34 also may be used to measure impedance, which can provide information relevant to positioning catheter 12. Impedance may be measured between any two electrodes 34 of catheter 12. In one example, however, impedance may be measured between: a) either a proximal-most electrode 34 or hub 36, and b) a distal-most electrode.
  • The impedance presented to injected current may be dependent on the conductivity of the fluid, or adjacent tissue, in the local area between a pair of sensing electrodes 34. The conductivity further may depend on the cross-sectional area of the blood vessel at the site of the sending electrodes 34. The impedance of an electrode 34 may vary depending on the medium in which it is resting. For example, an electrode 34 placed in a relatively large body of conductive fluid may have a lower impedance than one resting against a vessel wall. The impedance of an electrode 34 can therefore be used to determine whether it is adjacent to a vessel wall or resting in a larger body of conductive fluid.
  • In one example, when catheter 12 is inserted into a patient, electrodes 34 that are on a proximal portion of catheter 12 may have a higher impedance than other electrodes 34, because the proximal portion of catheter 12 may be positioned in tissue (e.g., fatty) near an insertion site, rather than resting in the fluid of a blood vessel. Electrodes 34 farther down the shaft of catheter 12, towards a central portion of catheter 12, might have progressively lower impedances as the diameter of the vessel increases (e.g., as the vessel approaches superior vena cava 24). Electrodes 34 on the portion of catheter 12 that is floating in fluid in superior vena cava 24 might have a low impedance. Electrodes 34 on the distal portion of catheter 12, at or near the tip of catheter 12, might be in direct contact with the vessel wall and therefore may have a higher impedance. A graph of the impedances of all of the electrodes 34 in this example may have a U-shaped curvature, as impedances may be higher at each end of catheter 12 and lower towards the central portion of catheter 12. The change in impedance of an electrode 34 as it progresses through the patient's vessels can provide information about the location of that electrode 34. In addition, the differences in impedances of electrodes 34 along the length of catheter 12 may provide information about the placement of catheter 12.
  • In one example, catheter 12 may be placed in a vessel that varies in diameter, with distal electrodes 34 resting in a desired vessel (e.g., in superior vena cava 24). The impedances of different, more proximal electrodes would be expected to vary depending on their position in the venous system. In one example, catheter 12, when placed in a desired position, would be expected to include: 1) electrodes 34 whose impedances are reduced as the electrodes 34 approach the wall of a vessel (e.g., superior vena cava 24); and 2) electrodes 34 having impedance profiles with a desired shape. In one example, measured impedances may be compared to impedance thresholds or profiles stored in data storage 79, to determine if one or more electrodes 34 are properly placed.
  • In another example, the impedances of distal electrodes can be compared to the impedances of proximal electrodes as the catheter 12 is advanced through superior vena cava 24 towards the atrium. As the distal electrodes enter the atrium, the difference between the distal and proximal impedance measurements may exceed a predetermined threshold allowing the system 10 to provide an indication to the operator. Catheter 12 can then be withdrawn (or advanced depending on the application) to the desired location. Signal filtering, processing, and analytical techniques known in the art can be used to assess the impedance measurements in real time.
  • A catheter 12 that is under-inserted may have few or no electrodes 34 resting in the desired vessel (e.g., superior vena cava 24), which would result in electrode impedance profiles having different shapes than the desired shape. In addition, a catheter 12 that is over-inserted may have one or more electrodes 34 that are close to, or in contact with, the atrium, which may also result in impedance profiles having different shapes than the desired shape. In one example, the impedance of one or more electrodes 34 is monitored as catheter 12 is inserted into the patient and electrodes 34 move through the patient's venous system. Changes in the impedance profiles can be displayed to the health professional performing the insertion, and the impedance profiles can be used to confirm proper placement of catheter 12.
  • In one example, a method for positioning intravascular catheter 12 may include positioning catheter 12 in a first position in a venous system of a patient, wherein catheter 12 includes a plurality of electrodes 34, and each electrode 34 of the plurality of electrodes 34 is configured to emit electrical signals to stimulate a phrenic nerve; measuring an impedance between a first electrode 34 of the plurality of electrodes 34 and a second electrode; and based on the measured impedance, adjusting catheter 12 to a second position different from the first position.
  • In other examples, catheter 12 may include a strain gauge and/or an accelerometer (not shown). Either the strain gauge or the accelerometer may be placed at or near the distal end of catheter 12, in one of the lumens. The strain gauge could detect flex in a distal portion of catheter 12, and the accelerometer could detect movement/acceleration of the distal portion of catheter 12. Information from the strain gauge and/or accelerometer could be used to determine whether the distal end of catheter 12 is in the atrium (e.g., heartbeats may cause movement of the distal end of catheter 12). The strain gauge or the accelerometer could be an integral, permanent part of catheter 12 or could be positioned in a lumen of catheter 12 temporarily during positioning of catheter 12.
  • Electrode Selection and Determining Stimulation Parameters
  • Nerve signals acquired by sensing electrodes 34 may be used to select electrodes 34 for nerve stimulation. Electrodes 34 that are closer to a target nerve may sense nerve activity having a higher amplitude, while electrodes 34 that are farther from a target nerve may sense nerve activity having a lower amplitude. If a greater diaphragm response is desired, electrodes 34 that are closer to the nerve, as determined based on received nerve activity signals, may be selected for nerve stimulation. In other cases, if less diaphragm response is desired, electrodes 34 that are farther from the nerve, as determined based on received nerve activity signals, may be selected for nerve stimulation.
  • Typical nerve signals for, e.g., phrenic nerves, follow a pattern that has distinct characteristics (e.g., spectral characteristics and modulation over time). To select electrodes 34 for nerve stimulation, the sensed nerve signals from different electrodes 34 can be analyzed for their spectral and temporal characteristics. Of electrodes 34 having sensed signal patterns matching typical phrenic nerve activity, the optimal electrodes 34 can be selected based on the amplitude of the signal and how strongly the signal correlates to the typical pattern. In one example, a fast Fourier transform can be used to provide a correlation factor to a reference signal in near real-time. In another example, the sensed signals can be frequency filtered in the frequency range of interest, based on the typical characteristics of the phrenic nerve signal, and then analyzed over time to observe periods or bursts of activity in the frequency range of interest.
  • In one example, a method for selecting one or more electrodes for nerve stimulation may include inserting intravascular catheter 12 into: a) at least one of left subclavian vein 22 or left jugular vein 32, and b) superior vena cava 24, wherein catheter 12 includes a plurality of electrodes 34, and each electrode 34 of the plurality of electrodes 34 is configured to emit electrical signals to stimulate a nerve; using one or more electrodes 34 of the plurality of electrodes 34 to acquire an electrical signal emitted from the nerve; based on the acquired electrical signal, selecting an electrode 34 or an electrode combination for a nerve stimulation; and using the selected electrode 34 or electrode combination, stimulating the nerve.
  • The processed nerve activity waveforms additionally may be used to determine parameters for nerve stimulation. The processed waveforms may provide information regarding intrinsic breath rate (e.g., if the patient is attempting to breathe on his/her own) and nerve signal amplitude. The stimulation parameters may be adjusted based on the breath rate of previous stimulated breaths (e.g., to increase or decrease the breath rate, as sensed by the sensing electrodes) and nerve activity resulting from stimulation during previous breaths (e.g., to increase or decrease the strength of stimulation). Various parameters that may be adjusted include stimulation pulse amplitude, stimulation pulse width, stimulation pulse frequency, stimulation duration, and the interval between stimulations/pulse trains (e.g., stimulated breath rate). Accordingly, sensed nerve activity signals may be used to determine and adjust the nerve stimulation parameters in a closed-loop system.
  • Impedance information may be used to determine a breath rate of the patient in order to adjust nerve stimulation parameters (e.g., stimulation pulse amplitude, stimulation pulse width, stimulation pulse frequency, stimulation duration, and the interval between stimulations/pulse trains (e.g., stimulated breath rate)). Electrical impedance of lung tissue changes as a function of air content. Accordingly, the electrical impedance of the thorax changes during inhalation and exhalation. The thorax presents an electrical impedance that includes two components: a relatively constant value and a varying value. Changes in impedance may result from the following two effects during inspiration: 1) there is an increase in the gas volume of the chest in relation to the fluid volume, which may cause conductivity to decrease, and 2) the length of the conductance path (e.g., between two electrodes) increases when the lungs expand. These effects may cause impedance to increase during inspiration. There is an approximately linear correlation between the impedance changes and the volume of respirated air. The varying component of impedance (i.e., respirative impedance) generates a varying voltage component when current is injected (e.g., by electrodes 34). This varying voltage component can then be used to determine the person's breathing rate.
  • Information from blood gas sensor 62 may be used by a health professional, or by controller 64, to adjust stimulation parameters. For example, if blood O2 levels are low (or blood CO2 levels are high) controller 64 may send a signal to electrodes 34 to emit stimulation signals having a higher charge (amplitude×pulse width) or frequency, and may stimulate a sigh breath. Conversely, if blood O2 levels are high (or blood CO2 levels are low), controller 64 may cause electrodes 34 to emit stimulation signals having a lower charge or frequency. Based on information from blood gas sensor 62, the following parameters can be adjusted: stimulation pulse amplitude, stimulation pulse width, stimulation pulse frequency, stimulation duration, and the interval between stimulations/pulse trains (e.g., stimulated breath rate).
  • For any of the parameter adjustments described herein, increasing stimulation pulse amplitude, width and/or frequency may increase lung volume during a stimulated breath. Increasing stimulation duration may increase lung volume and/or increase the amount of time air remains in the lungs during a stimulated breath, allowing for an extended gas exchange period. Increasing the stimulated breath rate may allow for additional gas exchange periods over a given period of time, which may increase the amount and/or speed of gas exchange.
  • The system 10 and catheter 12 described herein may include any combination of sensing features. For example, catheter 12 may be configured to sense ECG, impedance, nerve activity, blood gas levels, and CVP, and the system 10 may be configured to position catheter 12, select electrodes 34 for stimulation, and select stimulation parameters based on one or more types of information received by sensors or electrodes 34.
  • Accordingly, the various visualization and sensing functions of system 10 may assist a user in one or more of positioning a transvascular catheter, selecting optimal electrodes for nerve stimulation, or selecting or adjusting parameters for nerve stimulation.
  • While principles of the present disclosure are described herein with reference to illustrative embodiments for particular applications, it should be understood that the disclosure is not limited thereto. Those having ordinary skill in the art and access to the teachings provided herein will recognize additional modifications, applications, embodiments, and substitution of equivalents all fall within the scope of the embodiments described herein. Accordingly, the invention is not to be considered as limited by the foregoing description.

Claims (30)

1. A method for positioning an intravascular catheter, comprising:
inserting the intravascular catheter into a venous system of a patient, wherein the catheter includes a plurality of electrodes, and multiple electrodes of the plurality of electrodes are configured to emit electrical signals;
positioning a distal portion of the catheter in a first position;
using one or more electrodes of the plurality of electrodes to acquire a first ECG signal and a second ECG signal;
determining a difference between the first ECG signal and the second ECG signal;
comparing the difference to a value;
based on the comparison of the difference to the value, adjusting the distal portion of the catheter to a second position different from the first position;
identifying at least one first electrode of the plurality of electrodes to stimulate a first nerve;
identifying at least one second electrode of the plurality of electrodes to stimulate a second nerve; and
stimulating at least one of the first and second nerves to cause a contraction of a respiratory muscle.
2. The method of claim 1, wherein inserting the intravascular catheter into the venous system includes inserting the intravascular catheter into: 1) at least one of a left subclavian, axillary, cephalic, cardiophrenic, brachial, radial, or left jugular vein, and 2) a superior vena cava.
3. The method of claim 1, wherein the first position is proximate an atrium of a heart of the patient, and the second position is in a superior vena cava.
4. (canceled)
5. The method of claim 1, wherein the first ECG signal is acquired by one or more electrodes that are positioned on a proximal portion of the catheter and are configured to stimulate the first nerve, and the second ECG signal is acquired by one or more electrodes that are positioned on a distal portion of the catheter and are configured to stimulate the second nerve.
6. (canceled)
7. The method of claim 1, wherein the second position is farther from a heart of the patient than the first position.
8. The method of claim 1, further comprising using one or more electrodes of the plurality of electrodes to sense at least one of an impedance or nerve activity.
9. The method of claim 1, wherein each of the at least one first electrode and the at least one second electrode is a combination of electrodes.
10. A method for positioning an intravascular catheter, comprising:
inserting the intravascular catheter into: 1) at least one of a left subclavian vein or a left jugular vein, and 2) a superior vena cava, wherein the catheter includes a plurality of electrodes, and the plurality of electrodes includes a proximal set of electrodes positioned proximate a left phrenic nerve and a distal set of electrodes positioned proximate a right phrenic nerve;
using one or more electrodes of the plurality of electrodes to acquire a first ECG signal and a second ECG signal;
determining a difference between the first ECG signal and the second ECG signal;
comparing the difference to a value;
based on the comparison of the difference to the value, withdrawing the catheter away from a heart of a patient;
stimulating the left phrenic nerve using one or more electrodes of the proximal set of electrodes; and
stimulating the right phrenic nerve using one or more electrodes of the distal set of electrodes.
11. (canceled)
12. The method of claim 10, wherein the step of withdrawing the catheter away from the heart causes a change in an amplitude of a P-wave of the first ECG signal or the second ECG signal.
13. The method of claim 10, wherein the first ECG signal is acquired by one or more electrodes of the proximal set of electrodes, and the second ECG signal is acquired by one or more electrodes of the distal set of electrodes.
14. The method of claim 10, a wherein the difference between the first ECG signal and the second ECG signal is a difference between a P-wave of the first ECG signal and a P-wave of the second ECG signal.
15. The method of claim 10, wherein the difference exceeds the value when the catheter is advanced into an atrium of the heart.
16. The method of claim 10, wherein a hub coupled to the catheter and positioned exterior to the patient is used with the one or more electrodes of the plurality of electrodes to acquire the ECG signal.
17. The method of claim 10, further comprising monitoring the first ECG signal and the second ECG signal as a distal end of the catheter is inserted into the at least one of the left subclavian vein or the left jugular vein and advanced into the superior vena cava.
18. A method for positioning an intravascular catheter, comprising:
inserting the intravascular catheter into a venous system of a patient, wherein the catheter includes a plurality of proximal electrodes and a plurality of distal electrodes;
using one or more electrodes of the plurality of proximal electrodes to acquire a first ECG signal, and using one or more electrodes of the plurality of distal electrodes to acquire a second ECG signal;
determining a difference between the first ECG signal and the second ECG signal;
comparing the difference to a value;
based on the comparison of the difference to the value, adjusting a position of the catheter;
stimulating the first nerve using one or more of the plurality of proximal electrodes; and
stimulating the second nerve using one or more of the plurality of distal electrodes.
19. The method of claim 18, wherein the first nerve is a left phrenic nerve, and the second nerve is a right phrenic nerve.
20. The method of claim 18, wherein the difference between the first ECG signal and the second ECG signal is a difference between an amplitude of a portion of the first ECG signal and an amplitude of a portion of the second ECG signal.
21. The method of claim 18, wherein the steps of determining the difference and comparing occur a plurality of times during the inserting step.
22. The method of claim 18, wherein adjusting the position of the catheter includes moving the catheter away from a heart.
23. The method of claim 18, wherein at least one of stimulating the first nerve or stimulating the second nerve causes a contraction of a diaphragm.
24. The method of claim 18, further comprising sensing activity of the first nerve using one or more of the proximal electrodes and sensing activity of the second nerve using one or more of the distal electrodes.
25. A method for positioning an intravascular catheter, comprising:
inserting the intravascular catheter into: 1) at least one of a left subclavian vein or a left jugular vein, and 2) a superior vena cava, wherein the catheter includes a plurality of proximal electrodes configured to be positioned proximate a left phrenic nerve and a plurality of distal electrodes configured to be positioned proximate a right phrenic nerve;
at multiple positions of the catheter during the inserting step, using one or more electrodes of the plurality of proximal electrodes to acquire a first ECG signal, and using one or more electrodes of the plurality of distal electrodes to acquire a second ECG signal;
determining a difference between the first ECG signal and the second ECG signal at several of the multiple positions;
comparing each difference to a value;
based on the comparisons of each difference to the value, determining a desired position of the catheter for nerve stimulation;
stimulating the left phrenic nerve using one or more of the plurality of proximal electrodes; and
stimulating the right phrenic nerve using one of more of the plurality of distal electrodes.
26. The method of claim 25, further comprising advancing a distal end of the catheter into a region proximate an atrium of a heart.
27. The method of claim 26, wherein one of the multiple positions is a position in which the distal end of the catheter is proximate the atrium of the heart, and in the position, the comparison indicates a difference between an amplitude of the first ECG signal and an amplitude of the second ECG signal that exceeds the value.
28. The method of claim 27, further comprising moving the catheter away from the heart.
29. The method of claim 25, wherein stimulating the left phrenic nerve causes a diaphragm contraction, and stimulating the right phrenic nerve causes a diaphragm contraction.
30. The method of claim 25, wherein the proximal electrodes used to acquire the first ECG signal are configured to stimulate the left phrenic nerve, and the distal electrodes used to acquire the second ECG signal are configured to stimulate the right phrenic nerve.
US15/666,989 2017-08-02 2017-08-02 Systems and methods for intravascular catheter positioning and/or nerve stimulation Active US10195429B1 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
US15/666,989 US10195429B1 (en) 2017-08-02 2017-08-02 Systems and methods for intravascular catheter positioning and/or nerve stimulation
US15/704,439 US10039920B1 (en) 2017-08-02 2017-09-14 Systems and methods for intravascular catheter positioning and/or nerve stimulation
PCT/US2018/043661 WO2019027757A2 (en) 2017-08-02 2018-07-25 Systems and methods for intravascular catheter positioning and/or nerve stimulation
EP18752951.6A EP3661589A2 (en) 2017-08-02 2018-07-25 Systems and methods for intravascular catheter positioning and/or nerve stimulation
CN201880062545.1A CN111225710A (en) 2017-08-02 2018-07-25 Systems and methods for intravascular catheter positioning and/or neural stimulation
JP2020505459A JP7175027B2 (en) 2017-08-02 2018-07-25 Systems and methods for intravascular catheter placement and/or nerve stimulation
AU2018309630A AU2018309630A1 (en) 2017-08-02 2018-07-25 Systems and methods for intravascular catheter positioning and/or nerve stimulation
US16/222,299 US11090489B2 (en) 2017-08-02 2018-12-17 Systems and methods for intravascular catheter positioning and/or nerve stimulation
US16/802,711 US10926087B2 (en) 2017-08-02 2020-02-27 Systems and methods for intravascular catheter positioning and/or nerve stimulation
US17/371,316 US20210330968A1 (en) 2017-08-02 2021-07-09 Intravascular catheter methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/666,989 US10195429B1 (en) 2017-08-02 2017-08-02 Systems and methods for intravascular catheter positioning and/or nerve stimulation

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US15/704,439 Continuation US10039920B1 (en) 2017-08-02 2017-09-14 Systems and methods for intravascular catheter positioning and/or nerve stimulation
US16/222,299 Continuation US11090489B2 (en) 2017-08-02 2018-12-17 Systems and methods for intravascular catheter positioning and/or nerve stimulation

Publications (2)

Publication Number Publication Date
US10195429B1 US10195429B1 (en) 2019-02-05
US20190038897A1 true US20190038897A1 (en) 2019-02-07

Family

ID=63013876

Family Applications (5)

Application Number Title Priority Date Filing Date
US15/666,989 Active US10195429B1 (en) 2017-08-02 2017-08-02 Systems and methods for intravascular catheter positioning and/or nerve stimulation
US15/704,439 Active US10039920B1 (en) 2017-08-02 2017-09-14 Systems and methods for intravascular catheter positioning and/or nerve stimulation
US16/222,299 Active 2037-08-30 US11090489B2 (en) 2017-08-02 2018-12-17 Systems and methods for intravascular catheter positioning and/or nerve stimulation
US16/802,711 Active US10926087B2 (en) 2017-08-02 2020-02-27 Systems and methods for intravascular catheter positioning and/or nerve stimulation
US17/371,316 Pending US20210330968A1 (en) 2017-08-02 2021-07-09 Intravascular catheter methods

Family Applications After (4)

Application Number Title Priority Date Filing Date
US15/704,439 Active US10039920B1 (en) 2017-08-02 2017-09-14 Systems and methods for intravascular catheter positioning and/or nerve stimulation
US16/222,299 Active 2037-08-30 US11090489B2 (en) 2017-08-02 2018-12-17 Systems and methods for intravascular catheter positioning and/or nerve stimulation
US16/802,711 Active US10926087B2 (en) 2017-08-02 2020-02-27 Systems and methods for intravascular catheter positioning and/or nerve stimulation
US17/371,316 Pending US20210330968A1 (en) 2017-08-02 2021-07-09 Intravascular catheter methods

Country Status (6)

Country Link
US (5) US10195429B1 (en)
EP (1) EP3661589A2 (en)
JP (1) JP7175027B2 (en)
CN (1) CN111225710A (en)
AU (1) AU2018309630A1 (en)
WO (1) WO2019027757A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022179976A1 (en) * 2021-02-23 2022-09-01 B. Braun Melsungen Ag Method for checking a position and/or an orientation of a catheter tip of a catheter

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3228351B1 (en) 2012-03-05 2019-06-05 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus
CN104684614B (en) 2012-06-21 2017-10-17 西蒙·弗雷泽大学 The diaphragm pacing system and application method of intravascular
EP4115942B1 (en) 2017-06-30 2024-04-24 Lungpacer Medical Inc. System for prevention, moderation, and/or treatment of cognitive injury
US10195429B1 (en) 2017-08-02 2019-02-05 Lungpacer Medical Inc. Systems and methods for intravascular catheter positioning and/or nerve stimulation
EP3877043A4 (en) 2018-11-08 2022-08-24 Lungpacer Medical Inc. Stimulation systems and related user interfaces
EP3934746A1 (en) * 2019-03-04 2022-01-12 Boston Scientific Neuromodulation Corporation User-weighted closed loop adjustment of neuromodulation treatment
WO2020232333A1 (en) 2019-05-16 2020-11-19 Lungpacer Medical Inc. Systems and methods for sensing and stimulation
EP3983057A4 (en) 2019-06-12 2023-07-12 Lungpacer Medical Inc. Circuitry for medical stimulation systems
CN112451854A (en) * 2020-12-01 2021-03-09 中国康复研究中心 Implanted diaphragm pacemaker and control method thereof
DE102021110445A1 (en) 2021-02-17 2022-09-01 Stimit Ag Stimulation methods for electromagnetically or electrically controlled self-respiration
WO2023194399A1 (en) * 2022-04-08 2023-10-12 Koninklijke Philips N.V. Electrical traces along core wire for intraluminal physiology sensing guidewire and associated devices, systems, and methods

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8706235B2 (en) * 2011-07-27 2014-04-22 Medtronic, Inc. Transvenous method to induce respiration

Family Cites Families (487)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1693734A (en) 1923-06-29 1928-12-04 Mcintosh Electrical Corp Switching means for effecting electrotherapeutic treatment
US2532788A (en) 1948-01-03 1950-12-05 Stanley J Sarnoff Artificial respiration by electronic stimulation
US2664880A (en) 1951-11-23 1954-01-05 Jr Nathaniel B Wales Electric stimulator for artificial respiration
US3348548A (en) 1965-04-26 1967-10-24 William M Chardack Implantable electrode with stiffening stylet
US3470876A (en) 1966-09-28 1969-10-07 John Barchilon Dirigible catheter
US3835864A (en) 1970-09-21 1974-09-17 Rasor Ass Inc Intra-cardiac stimulator
US3769984A (en) 1971-03-11 1973-11-06 Sherwood Medical Ind Inc Pacing catheter with frictional fit lead attachment
US3817241A (en) 1972-02-16 1974-06-18 Henry And Carol Grausz Disposable central venous catheter and method of use
US3938502A (en) 1972-02-22 1976-02-17 Nicolaas Bom Apparatus with a catheter for examining hollow organs or bodies with the ultrasonic waves
US3804098A (en) 1972-04-17 1974-04-16 Medronic Inc Body implantable lead
US3896373A (en) 1972-11-30 1975-07-22 Stein Paul D Method and apparatus for determining cross-sectional area of a blood conduit and volumetric flow therethrough
US3847157A (en) 1973-06-18 1974-11-12 J Caillouette Medico-surgical tube
US3851641A (en) 1973-11-29 1974-12-03 J Toole Method and apparatus for determining internal impedance of animal body part
US3983881A (en) 1975-05-21 1976-10-05 Telectronics Pty. Limited Muscle stimulator
US4054881A (en) 1976-04-26 1977-10-18 The Austin Company Remote object position locater
US4114601A (en) 1976-08-09 1978-09-19 Micro Tec Instrumentation, Inc. Medical and surgical implement detection system
US4072146A (en) 1976-09-08 1978-02-07 Howes Randolph M Venous catheter device
USRE31873F1 (en) 1976-09-08 1988-11-15 Venous catheter device
US4143872A (en) 1977-04-07 1979-03-13 Hudson Oxygen Therapy Sales Company Lung volume exerciser
US4173228A (en) 1977-05-16 1979-11-06 Applied Medical Devices Catheter locating device
US4249539A (en) 1979-02-09 1981-02-10 Technicare Corporation Ultrasound needle tip localization system
US4317078A (en) 1979-10-15 1982-02-23 Ohio State University Research Foundation Remote position and orientation detection employing magnetic flux linkage
US4380237A (en) 1979-12-03 1983-04-19 Massachusetts General Hospital Apparatus for making cardiac output conductivity measurements
US4643201A (en) 1981-02-02 1987-02-17 Medtronic, Inc. Single-pass A-V lead
US4416289A (en) 1981-05-07 1983-11-22 Mccormick Laboratories, Inc. Circuits for determining very accurately the position of a device inside biological tissue
US4431005A (en) 1981-05-07 1984-02-14 Mccormick Laboratories, Inc. Method of and apparatus for determining very accurately the position of a device inside biological tissue
US4445501A (en) 1981-05-07 1984-05-01 Mccormick Laboratories, Inc. Circuits for determining very accurately the position of a device inside biological tissue
US4407294A (en) 1982-01-07 1983-10-04 Technicare Corporation Ultrasound tissue probe localization system
US4431006A (en) 1982-01-07 1984-02-14 Technicare Corporation Passive ultrasound needle probe locator
US4681117A (en) 1983-02-15 1987-07-21 Brodman Richard F Intracardiac catheter and a method for detecting myocardial ischemia
US4573481A (en) 1984-06-25 1986-03-04 Huntington Institute Of Applied Research Implantable electrode array
US4586923A (en) 1984-06-25 1986-05-06 Cordis Corporation Curving tip catheter
US4587975A (en) 1984-07-02 1986-05-13 Cardiac Pacemakers, Inc. Dimension sensitive angioplasty catheter
US4697595A (en) 1984-07-24 1987-10-06 Telectronics N.V. Ultrasonically marked cardiac catheters
YU132884A (en) 1984-07-26 1987-12-31 Branko Breyer Electrode cateter with ultrasonic marking
US4674518A (en) 1985-09-06 1987-06-23 Cardiac Pacemakers, Inc. Method and apparatus for measuring ventricular volume
US4683890A (en) 1985-12-23 1987-08-04 Brunswick Manufacturing Co., Inc. Method and apparatus for controlled breathing employing internal and external electrodes
US4827935A (en) 1986-04-24 1989-05-09 Purdue Research Foundation Demand electroventilator
US4771788A (en) 1986-07-18 1988-09-20 Pfizer Hospital Products Group, Inc. Doppler tip wire guide
US4852580A (en) 1986-09-17 1989-08-01 Axiom Medical, Inc. Catheter for measuring bioimpedance
US4830008A (en) 1987-04-24 1989-05-16 Meer Jeffrey A Method and system for treatment of sleep apnea
US4819662A (en) 1987-10-26 1989-04-11 Cardiac Pacemakers, Inc. Cardiac electrode with drug delivery capabilities
US4860769A (en) 1987-11-12 1989-08-29 Thomas J. Fogarty Implantable defibrillation electrode
CA1330285C (en) 1987-12-22 1994-06-21 Geoffrey S. Martin Triple lumen catheter
US4840182A (en) 1988-04-04 1989-06-20 Rhode Island Hospital Conductance catheter
US4944088A (en) 1988-05-25 1990-07-31 Medtronic, Inc. Ring electrode for multiconductor pacing leads
US4951682A (en) 1988-06-22 1990-08-28 The Cleveland Clinic Foundation Continuous cardiac output by impedance measurements in the heart
US4905698A (en) 1988-09-13 1990-03-06 Pharmacia Deltec Inc. Method and apparatus for catheter location determination
US4911174A (en) 1989-02-13 1990-03-27 Cardiac Pacemakers, Inc. Method for matching the sense length of an impedance measuring catheter to a ventricular chamber
US4957110A (en) 1989-03-17 1990-09-18 C. R. Bard, Inc. Steerable guidewire having electrodes for measuring vessel cross-section and blood flow
US4934049A (en) 1989-07-07 1990-06-19 Medtronic, Inc. Method for fabrication of a medical electrode
US4989617A (en) 1989-07-14 1991-02-05 Case Western Reserve University Intramuscular electrode for neuromuscular stimulation system
US5036848A (en) 1989-10-16 1991-08-06 Brunswick Biomedical Technologies, Inc. Method and apparatus for controlling breathing employing internal and external electrodes
US5005587A (en) 1989-11-13 1991-04-09 Pacing Systems, Inc. Braid Electrode leads and catheters and methods for using the same
US5254088A (en) 1990-02-02 1993-10-19 Ep Technologies, Inc. Catheter steering mechanism
US5042143A (en) 1990-02-14 1991-08-27 Medtronic, Inc. Method for fabrication of implantable electrode
US5115818A (en) 1990-02-14 1992-05-26 Medtronic, Inc. Implantable electrode
CH681351A5 (en) 1990-04-12 1993-03-15 Hans Baer Dr
US5265604A (en) 1990-05-14 1993-11-30 Vince Dennis J Demand - diaphragmatic pacing (skeletal muscle pressure modified)
US5056519A (en) 1990-05-14 1991-10-15 Vince Dennis J Unilateral diaphragmatic pacer
US5383923A (en) 1990-10-20 1995-01-24 Webster Laboratories, Inc. Steerable catheter having puller wire with shape memory
DE9015857U1 (en) 1990-11-21 1991-02-07 B. Braun Melsungen Ag, 3508 Melsungen, De
US5224491A (en) 1991-01-07 1993-07-06 Medtronic, Inc. Implantable electrode for location within a blood vessel
US5170802A (en) 1991-01-07 1992-12-15 Medtronic, Inc. Implantable electrode for location within a blood vessel
US5345936A (en) 1991-02-15 1994-09-13 Cardiac Pathways Corporation Apparatus with basket assembly for endocardial mapping
US5465717A (en) 1991-02-15 1995-11-14 Cardiac Pathways Corporation Apparatus and Method for ventricular mapping and ablation
US5456254A (en) 1991-02-15 1995-10-10 Cardiac Pathways Corp Flexible strip assembly having insulating layer with conductive pads exposed through insulating layer and device utilizing the same
US5146918A (en) 1991-03-19 1992-09-15 Medtronic, Inc. Demand apnea control of central and obstructive sleep apnea
US5184621A (en) 1991-05-29 1993-02-09 C. R. Bard, Inc. Steerable guidewire having electrodes for measuring vessel cross-section and blood flow
JP2582010B2 (en) 1991-07-05 1997-02-19 芳嗣 山田 Monitoring device for respiratory muscle activity
US5241957A (en) 1991-11-18 1993-09-07 Medtronic, Inc. Bipolar temporary pacing lead and connector and permanent bipolar nerve wire
US5324322A (en) 1992-04-20 1994-06-28 Case Western Reserve University Thin film implantable electrode and method of manufacture
US5843028A (en) 1992-05-11 1998-12-01 Medical Innovations Corporation Multi-lumen endoscopic catheter
US5411025A (en) 1992-06-30 1995-05-02 Cordis Webster, Inc. Cardiovascular catheter with laterally stable basket-shaped electrode array
DE69315704T3 (en) 1992-10-01 2002-08-01 Cardiac Pacemakers Inc STENT-LIKE STRUCTURE FOR DEFLICTION ELECTRODES
JP3526598B2 (en) 1992-12-04 2004-05-17 シー・アール・バード・インコーポレーテッド Catheter and independent handle / actuator for independent proximal and distal control
US5368564A (en) 1992-12-23 1994-11-29 Angeion Corporation Steerable catheter
US5330522A (en) 1992-12-29 1994-07-19 Siemens Pacesetter, Inc. Ring electrode for a multilumen lead and method of constructing a multilumen lead
US5706809A (en) 1993-01-29 1998-01-13 Cardima, Inc. Method and system for using multiple intravascular sensing devices to detect electrical activity
US5813399A (en) 1993-03-16 1998-09-29 Puritan Bennett Corporation System and method for closed loop airway pressure control during the inspiratory cycle of a breath in a patient ventilator using the exhalation valve as a microcomputer-controlled relief valve
WO1994027603A1 (en) 1993-06-01 1994-12-08 Cortex Pharmaceuticals, Inc. Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
US5348536A (en) 1993-08-02 1994-09-20 Quinton Instrument Company Coextruded catheter and method of forming
US5607462A (en) 1993-09-24 1997-03-04 Cardiac Pathways Corporation Catheter assembly, catheter and multi-catheter introducer for use therewith
US5486159A (en) 1993-10-01 1996-01-23 Mahurkar; Sakharam D. Multiple-lumen catheter
US5555618A (en) 1993-10-12 1996-09-17 Arrow International Investment Corp. Method of making electrode-carrying catheter
US5417208A (en) 1993-10-12 1995-05-23 Arrow International Investment Corp. Electrode-carrying catheter and method of making same
US5524632A (en) 1994-01-07 1996-06-11 Medtronic, Inc. Method for implanting electromyographic sensing electrodes
US5527358A (en) 1994-01-21 1996-06-18 Medtronic, Inc. Temporary medical electrical lead
JP3269125B2 (en) 1994-01-28 2002-03-25 東レ株式会社 Atopic dermatitis drug
US5476498A (en) 1994-08-15 1995-12-19 Incontrol, Inc. Coronary sinus channel lead and method
US5549655A (en) 1994-09-21 1996-08-27 Medtronic, Inc. Method and apparatus for synchronized treatment of obstructive sleep apnea
US5604231A (en) 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5678535A (en) 1995-04-21 1997-10-21 Dimarco; Anthony Fortunato Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient
US5584873A (en) 1995-05-08 1996-12-17 Medtronic, Inc. Medical lead with compression lumens
WO1997014473A1 (en) 1995-10-18 1997-04-24 Novartis Ag Thermopile powered transdermal drug delivery device
US6198970B1 (en) 1995-10-27 2001-03-06 Esd Limited Liability Company Method and apparatus for treating oropharyngeal respiratory and oral motor neuromuscular disorders with electrical stimulation
EP0955881B1 (en) 1995-11-17 2001-05-23 New York University Apparatus and method for pressure and temperature waveform analysis
US5697377A (en) 1995-11-22 1997-12-16 Medtronic, Inc. Catheter mapping system and method
US5716392A (en) 1996-01-05 1998-02-10 Medtronic, Inc. Minimally invasive medical electrical lead
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US5772693A (en) 1996-02-09 1998-06-30 Cardiac Control Systems, Inc. Single preformed catheter configuration for a dual-chamber pacemaker system
US5665103A (en) 1996-03-07 1997-09-09 Scimed Life Systems, Inc. Stent locating device
US6166048A (en) 1999-04-20 2000-12-26 Targacept, Inc. Pharmaceutical compositions for inhibition of cytokine production and secretion
US6449507B1 (en) 1996-04-30 2002-09-10 Medtronic, Inc. Method and system for nerve stimulation prior to and during a medical procedure
USRE38705E1 (en) 1996-04-30 2005-02-22 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US6006134A (en) 1998-04-30 1999-12-21 Medtronic, Inc. Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers
US20070208388A1 (en) 1996-04-30 2007-09-06 Jahns Scott E Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure
US7225019B2 (en) 1996-04-30 2007-05-29 Medtronic, Inc. Method and system for nerve stimulation and cardiac sensing prior to and during a medical procedure
US5913848A (en) 1996-06-06 1999-06-22 Luther Medical Products, Inc. Hard tip over-the-needle catheter and method of manufacturing the same
US5827192A (en) 1996-08-21 1998-10-27 Cleveland Clinic Foundation Method of determining the conductivity of blood
US5971933A (en) 1996-09-17 1999-10-26 Cleveland Clinic Foundation Method and apparatus to correct for electric field non-uniformity in conductance catheter volumetry
SE9603841D0 (en) 1996-10-18 1996-10-18 Pacesetter Ab A tissue stimulating apparatus
US5776111A (en) 1996-11-07 1998-07-07 Medical Components, Inc. Multiple catheter assembly
US5785706A (en) 1996-11-18 1998-07-28 Daig Corporation Nonsurgical mapping and treatment of cardiac arrhythmia using a catheter contained within a guiding introducer containing openings
US5782828A (en) 1996-12-11 1998-07-21 Irvine Biomedical, Inc. Ablation catheter with multiple flexible curves
US5755765A (en) 1997-01-24 1998-05-26 Cardiac Pacemakers, Inc. Pacing lead having detachable positioning member
US5916163A (en) 1997-03-07 1999-06-29 Ep Technologies, Inc. Graphical user interface for use with multiple electrode catheters
US5954761A (en) 1997-03-25 1999-09-21 Intermedics Inc. Implantable endocardial lead assembly having a stent
US5779732A (en) 1997-03-31 1998-07-14 Medtronic, Inc. Method and apparatus for implanting a film with an exandable stent
US5944022A (en) 1997-04-28 1999-08-31 American Cardiac Ablation Co. Inc. Catheter positioning system
US6869431B2 (en) 1997-07-08 2005-03-22 Atrionix, Inc. Medical device with sensor cooperating with expandable member
US5824027A (en) 1997-08-14 1998-10-20 Simon Fraser University Nerve cuff having one or more isolated chambers
US6479523B1 (en) 1997-08-26 2002-11-12 Emory University Pharmacologic drug combination in vagal-induced asystole
US6249708B1 (en) 1997-08-26 2001-06-19 Angeion Corporation Fluted channel construction for a multi-conductor catheter lead
US5922014A (en) 1997-09-02 1999-07-13 Medtronic, Inc. Single pass lead and method of use
US6024702A (en) 1997-09-03 2000-02-15 Pmt Corporation Implantable electrode manufactured with flexible printed circuit
US6123699A (en) 1997-09-05 2000-09-26 Cordis Webster, Inc. Omni-directional steerable catheter
US6179832B1 (en) 1997-09-11 2001-01-30 Vnus Medical Technologies, Inc. Expandable catheter having two sets of electrodes
US6171277B1 (en) 1997-12-01 2001-01-09 Cordis Webster, Inc. Bi-directional control handle for steerable catheter
US6120476A (en) 1997-12-01 2000-09-19 Cordis Webster, Inc. Irrigated tip catheter
US6183463B1 (en) 1997-12-01 2001-02-06 Cordis Webster, Inc. Bidirectional steerable cathether with bidirectional control handle
US6415187B1 (en) 1998-02-10 2002-07-02 Advanced Bionics Corporation Implantable, expandable, multicontact electrodes and insertion needle for use therewith
US6269269B1 (en) 1998-04-23 2001-07-31 Medtronic Inc. Method and apparatus for synchronized treatment of obstructive sleep apnea
US6251126B1 (en) 1998-04-23 2001-06-26 Medtronic Inc Method and apparatus for synchronized treatment of obstructive sleep apnea
US6161047A (en) 1998-04-30 2000-12-12 Medtronic Inc. Apparatus and method for expanding a stimulation lead body in situ
US6240320B1 (en) 1998-06-05 2001-05-29 Intermedics Inc. Cardiac lead with zone insulated electrodes
US6134478A (en) 1998-06-05 2000-10-17 Intermedics Inc. Method for making cardiac leads with zone insulated electrodes
US6002965A (en) 1998-06-10 1999-12-14 Katz; Amiram Self applied device and method for prevention of deep vein thrombosis
US6463327B1 (en) 1998-06-11 2002-10-08 Cprx Llc Stimulatory device and methods to electrically stimulate the phrenic nerve
US6292695B1 (en) 1998-06-19 2001-09-18 Wilton W. Webster, Jr. Method and apparatus for transvascular treatment of tachycardia and fibrillation
US6213960B1 (en) 1998-06-19 2001-04-10 Revivant Corporation Chest compression device with electro-stimulation
SE9802335D0 (en) 1998-06-30 1998-06-30 Siemens Elema Ab Breathing Help System
US6198974B1 (en) 1998-08-14 2001-03-06 Cordis Webster, Inc. Bi-directional steerable catheter
US7972323B1 (en) 1998-10-02 2011-07-05 Boston Scientific Scimed, Inc. Steerable device for introducing diagnostic and therapeutic apparatus into the body
FR2784300B1 (en) 1998-10-13 2000-12-08 Ela Medical Sa IMPLANTABLE LEFT VENTRICLE STIMULATION PROBE IN THE CORONARY VENOUS NETWORK FOR ACTIVE IMPLANTABLE MEDICAL DEVICE, IN PARTICULAR "MULTI-SITE" STIMULATOR
SE9803508D0 (en) 1998-10-14 1998-10-14 Siemens Elema Ab Assisted Breathing System
US6208881B1 (en) 1998-10-20 2001-03-27 Micropure Medical, Inc. Catheter with thin film electrodes and method for making same
US7076307B2 (en) 2002-05-09 2006-07-11 Boveja Birinder R Method and system for modulating the vagus nerve (10th cranial nerve) with electrical pulses using implanted and external components, to provide therapy neurological and neuropsychiatric disorders
US6212435B1 (en) 1998-11-13 2001-04-03 Respironics, Inc. Intraoral electromuscular stimulation device and method
EP1025822A1 (en) 1999-02-08 2000-08-09 Paul Hartmann Aktiengesellschaft Absorption body for a hygienic article
US6210339B1 (en) 1999-03-03 2001-04-03 Endosonics Corporation Flexible elongate member having one or more electrical contacts
US6161029A (en) 1999-03-08 2000-12-12 Medtronic, Inc. Apparatus and method for fixing electrodes in a blood vessel
DE19912635A1 (en) 1999-03-20 2000-09-21 Biotronik Mess & Therapieg Dilatable cardiac electrode arrangement for implantation, particularly in the coronary sinus of the heart
US6136021A (en) 1999-03-23 2000-10-24 Cardiac Pacemakers, Inc. Expandable electrode for coronary venous leads
US6593754B1 (en) 1999-04-01 2003-07-15 Actuant Corporation Compact subsurface object locator
US6216045B1 (en) 1999-04-26 2001-04-10 Advanced Neuromodulation Systems, Inc. Implantable lead and method of manufacture
US6126649A (en) 1999-06-10 2000-10-03 Transvascular, Inc. Steerable catheter with external guidewire as catheter tip deflector
EP1198271A4 (en) 1999-06-25 2009-01-21 Univ Emory Devices and methods for vagus nerve stimulation
EP1189649B1 (en) 1999-06-30 2005-06-15 University Of Florida Research Foundation, Inc. Ventilator monitor system
US6702780B1 (en) 1999-09-08 2004-03-09 Super Dimension Ltd. Steering configuration for catheter with rigid distal device
US6236892B1 (en) 1999-10-07 2001-05-22 Claudio A. Feler Spinal cord stimulation lead
US6295475B1 (en) 1999-10-27 2001-09-25 Pacesetter, Inc. Single-pass atrial ventricular lead with multiple atrial ring electrodes and a selective atrial electrode adaptor for the coronary sinus region
US7206636B1 (en) 1999-11-10 2007-04-17 Pacesetter, Inc. Pacing optimization based on changes in pulse amplitude and pulse amplitude variability
US6556873B1 (en) 1999-11-29 2003-04-29 Medtronic, Inc. Medical electrical lead having variable bending stiffness
US20020026228A1 (en) 1999-11-30 2002-02-28 Patrick Schauerte Electrode for intravascular stimulation, cardioversion and/or defibrillation
US6415183B1 (en) 1999-12-09 2002-07-02 Cardiac Pacemakers, Inc. Method and apparatus for diaphragmatic pacing
US6885888B2 (en) 2000-01-20 2005-04-26 The Cleveland Clinic Foundation Electrical stimulation of the sympathetic nerve chain
US6493590B1 (en) 2000-02-09 2002-12-10 Micronet Medical, Inc. Flexible band electrodes for medical leads
AU2001257582A1 (en) 2000-03-14 2001-09-24 Children's Medical Center Corporation, The Method for improving respiratory function and inhibiting muscular degeneration
US6397108B1 (en) 2000-04-03 2002-05-28 Medtronic Inc. Safety adaptor for temporary medical leads
US6638268B2 (en) 2000-04-07 2003-10-28 Imran K. Niazi Catheter to cannulate the coronary sinus
US6442413B1 (en) 2000-05-15 2002-08-27 James H. Silver Implantable sensor
US6508802B1 (en) 2000-05-23 2003-01-21 Cornell Research Foundation, Inc. Remote sensing gene therapy delivery device and method of administering a therapeutic solution to a heart
US6610713B2 (en) 2000-05-23 2003-08-26 North Shore - Long Island Jewish Research Institute Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US6695832B2 (en) 2000-06-01 2004-02-24 Twincath, Llc Multilumen catheter and methods for making the catheter
US6719749B1 (en) 2000-06-01 2004-04-13 Medical Components, Inc. Multilumen catheter assembly and methods for making and inserting the same
US6584362B1 (en) 2000-08-30 2003-06-24 Cardiac Pacemakers, Inc. Leads for pacing and/or sensing the heart from within the coronary veins
US7555349B2 (en) 2000-09-26 2009-06-30 Advanced Neuromodulation Systems, Inc. Lead body and method of lead body construction
US7149585B2 (en) 2001-03-30 2006-12-12 Micronet Medical, Inc. Lead body and method of lead body construction
US7499742B2 (en) 2001-09-26 2009-03-03 Cvrx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
US6757970B1 (en) 2000-11-07 2004-07-06 Advanced Bionics Corporation Method of making multi-contact electrode array
SE0004141D0 (en) 2000-11-13 2000-11-13 Siemens Elema Ab Method of adaptive triggering of breathing devices and a breathing device
US7212867B2 (en) 2000-12-07 2007-05-01 Medtronic, Inc. Directional brain stimulation and recording leads
US7519421B2 (en) 2001-01-16 2009-04-14 Kenergy, Inc. Vagal nerve stimulation using vascular implanted devices for treatment of atrial fibrillation
US6445953B1 (en) 2001-01-16 2002-09-03 Kenergy, Inc. Wireless cardiac pacing system with vascular electrode-stents
DE10103288A1 (en) 2001-01-25 2002-08-01 Patrick Schauerte Vascular lock for intravascular nerve stimulation and fluid infusion
DE10105383C2 (en) 2001-02-06 2003-06-05 Heptec Gmbh Anti-snoring device
ZA200306564B (en) 2001-02-26 2004-10-15 Optinose As Nasal devices.
US7167751B1 (en) 2001-03-01 2007-01-23 Advanced Bionics Corporation Method of using a fully implantable miniature neurostimulator for vagus nerve stimulation
US6585718B2 (en) 2001-05-02 2003-07-01 Cardiac Pacemakers, Inc. Steerable catheter with shaft support system for resisting axial compressive loads
CA2448912C (en) 2001-05-30 2012-01-03 Innersa Technology Implantable devices having a liquid crystal polymer substrate
JP4295086B2 (en) 2001-07-11 2009-07-15 ヌバシブ, インコーポレイテッド System and method for determining nerve proximity, nerve orientation, and pathology during surgery
US6569114B2 (en) 2001-08-31 2003-05-27 Biosense Webster, Inc. Steerable catheter with struts
US7974693B2 (en) 2001-08-31 2011-07-05 Bio Control Medical (B.C.M.) Ltd. Techniques for applying, configuring, and coordinating nerve fiber stimulation
EP2481338A3 (en) 2001-09-25 2012-09-05 Nuvasive, Inc. System for performing surgical procedures and assessments
US7168429B2 (en) 2001-10-12 2007-01-30 Ric Investments, Llc Auto-titration pressure support system and method of using same
US6934583B2 (en) 2001-10-22 2005-08-23 Pacesetter, Inc. Implantable lead and method for stimulating the vagus nerve
US6721603B2 (en) 2002-01-25 2004-04-13 Cyberonics, Inc. Nerve stimulation as a treatment for pain
WO2003068944A2 (en) 2002-02-13 2003-08-21 Dana-Farber Cancer Institute, Inc. METHODS AND COMPOSITION FOR MODULATING TYPE I MUSCLE FORMATION USING PGC-1α-
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US7620451B2 (en) 2005-12-29 2009-11-17 Ardian, Inc. Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US20030195571A1 (en) 2002-04-12 2003-10-16 Burnes John E. Method and apparatus for the treatment of central sleep apnea using biventricular pacing
WO2003094855A1 (en) 2002-05-08 2003-11-20 The Regents Of The University Of California System and method for treating cardiac arrhythmias with fibroblast cells
US7292890B2 (en) 2002-06-20 2007-11-06 Advanced Bionics Corporation Vagus nerve stimulation via unidirectional propagation of action potentials
SE0202537D0 (en) 2002-08-28 2002-08-28 Siemens Elema Ab Nerve stimulation apparatus
US20040064069A1 (en) 2002-09-30 2004-04-01 Reynolds Brian R. Medical device with support member
SE0203108D0 (en) 2002-10-22 2002-10-22 Siemens Elema Ab Multi-Electrode Catheter
US20050033137A1 (en) 2002-10-25 2005-02-10 The Regents Of The University Of Michigan Ablation catheters and methods for their use
US7277757B2 (en) 2002-10-31 2007-10-02 Medtronic, Inc. Respiratory nerve stimulation
US7130700B2 (en) 2002-11-19 2006-10-31 Medtronic, Inc. Multilumen body for an implantable medical device
US20040111139A1 (en) 2002-12-10 2004-06-10 Mccreery Douglas B. Apparatus and methods for differential stimulation of nerve fibers
US7613515B2 (en) 2003-02-03 2009-11-03 Enteromedics Inc. High frequency vagal blockage therapy
EP1599232B1 (en) 2003-02-21 2013-08-14 Electro-Cat, LLC System for measuring cross-sectional areas and pressure gradients in luminal organs
US7142903B2 (en) 2003-03-12 2006-11-28 Biosense Webster, Inc. Catheter with contractable mapping assembly
US7155278B2 (en) 2003-04-21 2006-12-26 Medtronic, Inc. Neurostimulation to treat effects of sleep apnea
EP3064242A1 (en) 2003-04-28 2016-09-07 Advanced Circulatory Systems Inc. Ventilator and methods for treating head trauma and low blood circulation
US20060111755A1 (en) 2003-05-16 2006-05-25 Stone Robert T Method and system to control respiration by means of neuro-electrical coded signals
US20060287679A1 (en) 2003-05-16 2006-12-21 Stone Robert T Method and system to control respiration by means of confounding neuro-electrical signals
US6999820B2 (en) 2003-05-29 2006-02-14 Advanced Neuromodulation Systems, Inc. Winged electrode body for spinal cord stimulation
CA2527909A1 (en) 2003-06-04 2005-01-06 Synecor Llc Intravascular electrophysiological system and methods
US7235070B2 (en) 2003-07-02 2007-06-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Ablation fluid manifold for ablation catheter
TW200503738A (en) 2003-07-16 2005-02-01 Tzu Chi Buddhist General Hospital Method for extracting antineoplastic components from bupleurum scorzonerifolium
US7840270B2 (en) 2003-07-23 2010-11-23 Synapse Biomedical, Inc. System and method for conditioning a diaphragm of a patient
US20050027338A1 (en) 2003-07-29 2005-02-03 Advanced Neuromodulation Systems, Inc. Stretchable lead body, method of manufacture, and system
US20050033136A1 (en) 2003-08-01 2005-02-10 Assaf Govari Catheter with electrode strip
EP1670547B1 (en) 2003-08-18 2008-11-12 Cardiac Pacemakers, Inc. Patient monitoring system
US7887493B2 (en) 2003-09-18 2011-02-15 Cardiac Pacemakers, Inc. Implantable device employing movement sensing for detecting sleep-related disorders
US7662101B2 (en) 2003-09-18 2010-02-16 Cardiac Pacemakers, Inc. Therapy control based on cardiopulmonary status
EP1660004A4 (en) 2003-08-18 2017-05-31 Breathe Technologies, Inc. Method and device for non-invasive ventilation with nasal interface
US7591265B2 (en) 2003-09-18 2009-09-22 Cardiac Pacemakers, Inc. Coordinated use of respiratory and cardiac therapies for sleep disordered breathing
US7502650B2 (en) 2003-09-22 2009-03-10 Cvrx, Inc. Baroreceptor activation for epilepsy control
US8147486B2 (en) 2003-09-22 2012-04-03 St. Jude Medical, Atrial Fibrillation Division, Inc. Medical device with flexible printed circuit
US20050070981A1 (en) 2003-09-29 2005-03-31 Sumit Verma Active fixation coronary sinus lead apparatus
NO319063B1 (en) 2003-10-06 2005-06-13 Laerdal Medical As Medical patient simulator
US20080288010A1 (en) 2003-10-15 2008-11-20 Rmx, Llc Subcutaneous diaphragm stimulation device and method for use
US7970475B2 (en) 2003-10-15 2011-06-28 Rmx, Llc Device and method for biasing lung volume
US8160711B2 (en) 2003-10-15 2012-04-17 Rmx, Llc Multimode device and method for controlling breathing
US20080215106A1 (en) 2003-10-15 2008-09-04 Chang Lee Thoracoscopically implantable diaphragm stimulator
US20080288015A1 (en) 2003-10-15 2008-11-20 Rmx, Llc Diaphragm stimulation device and method for use with cardiovascular or heart patients
US8467876B2 (en) 2003-10-15 2013-06-18 Rmx, Llc Breathing disorder detection and therapy delivery device and method
US20080161878A1 (en) 2003-10-15 2008-07-03 Tehrani Amir J Device and method to for independently stimulating hemidiaphragms
US7979128B2 (en) 2003-10-15 2011-07-12 Rmx, Llc Device and method for gradually controlling breathing
US8244358B2 (en) 2003-10-15 2012-08-14 Rmx, Llc Device and method for treating obstructive sleep apnea
US8140164B2 (en) 2003-10-15 2012-03-20 Rmx, Llc Therapeutic diaphragm stimulation device and method
US20110288609A1 (en) 2003-10-15 2011-11-24 Rmx, Llc Therapeutic diaphragm stimulation device and method
US8265759B2 (en) 2003-10-15 2012-09-11 Rmx, Llc Device and method for treating disorders of the cardiovascular system or heart
US9259573B2 (en) 2003-10-15 2016-02-16 Rmx, Llc Device and method for manipulating exhalation
US20120158091A1 (en) 2003-10-15 2012-06-21 Rmx, Llc Therapeutic diaphragm stimulation device and method
US20060167523A1 (en) 2003-10-15 2006-07-27 Tehrani Amir J Device and method for improving upper airway functionality
US20060074449A1 (en) 2003-11-03 2006-04-06 Stephen Denker Intravascular stimulation system with wireless power supply
US7077823B2 (en) 2003-11-19 2006-07-18 Biosense Webster, Inc. Bidirectional steerable catheter with slidable mated puller wires
US7802571B2 (en) 2003-11-21 2010-09-28 Tehrani Fleur T Method and apparatus for controlling a ventilator
US8224456B2 (en) 2003-11-25 2012-07-17 Advanced Neuromodulation Systems, Inc. Directional stimulation lead and orientation system
US7519425B2 (en) 2004-01-26 2009-04-14 Pacesetter, Inc. Tiered therapy for respiratory oscillations characteristic of Cheyne-Stokes respiration
US7363085B1 (en) 2004-01-26 2008-04-22 Pacesetters, Inc. Augmenting hypoventilation
US7421296B1 (en) 2004-01-26 2008-09-02 Pacesetter, Inc. Termination of respiratory oscillations characteristic of Cheyne-Stokes respiration
WO2005077268A1 (en) 2004-02-18 2005-08-25 Maquet Critical Care Ab Method and device using myoelectrical activity for optimizing a patient’s ventilatory assist
US7569029B2 (en) 2004-04-12 2009-08-04 Clark Timothy W I Multi-lumen catheter
US7082331B1 (en) 2004-04-21 2006-07-25 Pacesetter, Inc. System and method for applying therapy during hyperpnea phase of periodic breathing using an implantable medical device
US8412348B2 (en) 2004-05-06 2013-04-02 Boston Scientific Neuromodulation Corporation Intravascular self-anchoring integrated tubular electrode body
US20070106357A1 (en) 2005-11-04 2007-05-10 Stephen Denker Intravascular Electronics Carrier Electrode for a Transvascular Tissue Stimulation System
US7747323B2 (en) 2004-06-08 2010-06-29 Cardiac Pacemakers, Inc. Adaptive baroreflex stimulation therapy for disordered breathing
US7591799B2 (en) 2004-06-14 2009-09-22 Biosense Webster, Inc. Steering mechanism for bi-directional catheter
US7225016B1 (en) 2004-06-16 2007-05-29 Pacesetter, Inc. Implantable medical device with nerve signal sensing
US7371220B1 (en) 2004-06-30 2008-05-13 Pacesetter, Inc. System and method for real-time apnea/hypopnea detection using an implantable medical system
US7962215B2 (en) 2004-07-23 2011-06-14 Synapse Biomedical, Inc. Ventilatory assist system and methods to improve respiratory function
EP1621247A1 (en) 2004-07-30 2006-02-01 MAN DWE GmbH Carry out of exothermic gas-phase reactions
US20060058852A1 (en) 2004-09-10 2006-03-16 Steve Koh Multi-variable feedback control of stimulation for inspiratory facilitation
US7340302B1 (en) 2004-09-27 2008-03-04 Pacesetter, Inc. Treating sleep apnea in patients using phrenic nerve stimulation
US9026228B2 (en) 2004-10-21 2015-05-05 Medtronic, Inc. Transverse tripole neurostimulation lead, system and method
US10537741B2 (en) 2004-12-03 2020-01-21 Boston Scientific Neuromodulation Corporation System and method for choosing electrodes in an implanted stimulator device
US20060122661A1 (en) 2004-12-03 2006-06-08 Mandell Lee J Diaphragmatic pacing with activity monitor adjustment
KR20070106995A (en) 2004-12-08 2007-11-06 벤투스 메디컬, 인코포레이티드 Respiratory devices and methods of use
US20060130833A1 (en) 2004-12-16 2006-06-22 Magdy Younes Treatment of obstructive sleep apnea
US7869865B2 (en) 2005-01-07 2011-01-11 Biosense Webster, Inc. Current-based position sensing
US7891085B1 (en) 2005-01-11 2011-02-22 Boston Scientific Neuromodulation Corporation Electrode array assembly and method of making same
US8019439B2 (en) 2005-01-11 2011-09-13 Boston Scientific Neuromodulation Corporation Lead assembly and method of making same
US7269459B1 (en) 2005-02-08 2007-09-11 Pacesetter, Inc. Implantable cardiac device with selectable tiered sleep apnea therapies and method
US7255511B2 (en) 2005-02-22 2007-08-14 Dolan Kevin P Releasable dovetail corner joint
US7920915B2 (en) 2005-11-16 2011-04-05 Boston Scientific Neuromodulation Corporation Implantable stimulator
US7363086B1 (en) 2005-03-21 2008-04-22 Pacesetter, Inc. Capture verification in respiratory diaphragm stimulation
US20060217791A1 (en) 2005-03-23 2006-09-28 Arrow International, Inc. Multi-lumen catheter having external electrical leads
US7499748B2 (en) 2005-04-11 2009-03-03 Cardiac Pacemakers, Inc. Transvascular neural stimulation device
US7630763B2 (en) 2005-04-20 2009-12-08 Cardiac Pacemakers, Inc. Thoracic or intracardiac impedance detection with automatic vector selection
US7676275B1 (en) 2005-05-02 2010-03-09 Pacesetter, Inc. Endovascular lead for chronic nerve stimulation
US7561923B2 (en) 2005-05-09 2009-07-14 Cardiac Pacemakers, Inc. Method and apparatus for controlling autonomic balance using neural stimulation
US7617003B2 (en) 2005-05-16 2009-11-10 Cardiac Pacemakers, Inc. System for selective activation of a nerve trunk using a transvascular reshaping lead
US7949412B1 (en) 2005-06-02 2011-05-24 Advanced Bionics, Llc Coated electrode array having uncoated electrode contacts
US7553305B2 (en) 2005-06-09 2009-06-30 Enpath Medical, Inc. Push-pull wire anchor
US8036750B2 (en) 2005-06-13 2011-10-11 Cardiac Pacemakers, Inc. System for neural control of respiration
US20070005053A1 (en) 2005-06-30 2007-01-04 Dando Jeremy D Ablation catheter with contoured openings in insulated electrodes
US7879030B2 (en) 2005-07-27 2011-02-01 St. Jude Medical, Atrial Fibrillation Division, Inc. Multipolar, virtual-electrode catheter with at least one surface electrode and method for ablation
US7416552B2 (en) 2005-08-22 2008-08-26 St. Jude Medical, Atrial Fibrillation Division, Inc. Multipolar, multi-lumen, virtual-electrode catheter with at least one surface electrode and method for ablation
US7519426B1 (en) 2005-10-07 2009-04-14 Pacesetter, Inc. Techniques for reducing orthostatic hypotension
US7771388B2 (en) 2005-10-12 2010-08-10 Daniel Olsen Steerable catheter system
US20070112402A1 (en) 2005-10-19 2007-05-17 Duke University Electrode systems and related methods for providing therapeutic differential tissue stimulation
US7636600B1 (en) 2005-10-21 2009-12-22 Pacesetter, Inc. Pressure monitoring for apnea prevention and/or therapy
US7616990B2 (en) 2005-10-24 2009-11-10 Cardiac Pacemakers, Inc. Implantable and rechargeable neural stimulator
AU2006311701B2 (en) 2005-11-08 2012-08-30 Custom Medical Applications, Inc. Reinforced catheter with articulated distal tip
US10406366B2 (en) 2006-11-17 2019-09-10 Respicardia, Inc. Transvenous phrenic nerve stimulation system
US8696656B2 (en) 2005-11-18 2014-04-15 Medtronic Cryocath Lp System and method for monitoring bioimpedance and respiration
EP1960038B8 (en) 2005-11-18 2021-04-07 Respicardia, Inc. System to modulate phrenic nerve to prevent sleep apnea
US20220212005A9 (en) 2005-11-18 2022-07-07 Zoll Respicardia, Inc. Transvenous Phrenic Nerve Stimulation System
EP1968693A4 (en) 2005-12-22 2011-04-27 Proteus Biomedical Inc Implantable integrated circuit
US7672728B2 (en) 2005-12-28 2010-03-02 Cardiac Pacemakers, Inc. Neural stimulator to treat sleep disordered breathing
US8281792B2 (en) 2005-12-31 2012-10-09 John W Royalty Electromagnetic diaphragm assist device and method for assisting a diaphragm function
US7813805B1 (en) 2006-01-11 2010-10-12 Pacesetter, Inc. Subcardiac threshold vagal nerve stimulation
US7763034B2 (en) 2006-01-24 2010-07-27 Medtronic, Inc. Transobturator lead implantation for pelvic floor stimulation
US7347695B2 (en) 2006-02-03 2008-03-25 Ware Linda M Chronic obstructive pulmonary disease simulator
JP5256048B2 (en) 2006-02-03 2013-08-07 シネコー・エルエルシー Intravascular devices for neuromodulation
WO2007098367A2 (en) 2006-02-16 2007-08-30 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Method and apparatus for stimulating a denervated muscle
US7810497B2 (en) 2006-03-20 2010-10-12 Ric Investments, Llc Ventilatory control system
US7900626B2 (en) 2006-04-17 2011-03-08 Daly Robert W Method and system for controlling breathing
US20070288076A1 (en) 2006-06-07 2007-12-13 Cherik Bulkes Biological tissue stimulator with flexible electrode carrier
CA2622731C (en) 2006-06-08 2011-06-07 Surgical Solutions Llc Medical device with articulating shaft
US20080039916A1 (en) 2006-08-08 2008-02-14 Olivier Colliou Distally distributed multi-electrode lead
US8121692B2 (en) 2006-08-30 2012-02-21 Cardiac Pacemakers, Inc. Method and apparatus for neural stimulation with respiratory feedback
US8050765B2 (en) 2006-08-30 2011-11-01 Cardiac Pacemakers, Inc. Method and apparatus for controlling neural stimulation during disordered breathing
US20080065002A1 (en) 2006-09-07 2008-03-13 Neurosystec Corporation Catheter for Localized Drug Delivery and/or Electrical Stimulation
WO2008045877A2 (en) 2006-10-10 2008-04-17 St. Jude Medical, Atrial Fibrillation Division, Inc. Electrode tip and ablation system
US7794407B2 (en) 2006-10-23 2010-09-14 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
US8388546B2 (en) 2006-10-23 2013-03-05 Bard Access Systems, Inc. Method of locating the tip of a central venous catheter
WO2008070145A2 (en) 2006-12-06 2008-06-12 Medtronic, Inc. User interface with toolbar for programming electrical stimulation therapy
WO2008070809A2 (en) 2006-12-06 2008-06-12 Spinal Modulation, Inc. Implantable flexible circuit leads and methods of use
US8280513B2 (en) 2006-12-22 2012-10-02 Rmx, Llc Device and method to treat flow limitations
US8909341B2 (en) 2007-01-22 2014-12-09 Respicardia, Inc. Device and method for the treatment of breathing disorders and cardiac disorders
WO2008092246A1 (en) 2007-01-29 2008-08-07 Simon Fraser University Transvascular nerve stimulation apparatus and methods
US20080183186A1 (en) 2007-01-30 2008-07-31 Cardiac Pacemakers, Inc. Method and apparatus for delivering a transvascular lead
US20080183264A1 (en) 2007-01-30 2008-07-31 Cardiac Pacemakers, Inc. Electrode configurations for transvascular nerve stimulation
US8244378B2 (en) 2007-01-30 2012-08-14 Cardiac Pacemakers, Inc. Spiral configurations for intravascular lead stability
US20080183187A1 (en) 2007-01-30 2008-07-31 Cardiac Pacemakers, Inc. Direct delivery system for transvascular lead
US7917230B2 (en) 2007-01-30 2011-03-29 Cardiac Pacemakers, Inc. Neurostimulating lead having a stent-like anchor
US7949409B2 (en) 2007-01-30 2011-05-24 Cardiac Pacemakers, Inc. Dual spiral lead configurations
US20080183255A1 (en) 2007-01-30 2008-07-31 Cardiac Pacemakers, Inc. Side port lead delivery system
US20080183265A1 (en) 2007-01-30 2008-07-31 Cardiac Pacemakers, Inc. Transvascular lead with proximal force relief
US7819883B2 (en) 2007-03-13 2010-10-26 Cardiac Pacemakers, Inc. Method and apparatus for endoscopic access to the vagus nerve
GB0707906D0 (en) 2007-04-24 2007-05-30 Apparatus for detecting the position of a catheter
EP2148712B1 (en) 2007-04-27 2018-10-31 Maquet Critical Care AB Control unit and display unit for an emg controlled ventilator
US10492729B2 (en) 2007-05-23 2019-12-03 St. Jude Medical, Cardiology Division, Inc. Flexible high-density mapping catheter tips and flexible ablation catheter tips with onboard high-density mapping electrodes
EP2170458A1 (en) 2007-06-13 2010-04-07 E- Pacing, Inc. Implantable devices and methods for stimulation of cardiac or other tissues
WO2008157180A1 (en) 2007-06-13 2008-12-24 E-Pacing, Inc. Implantable devices and methods for stimulation of cardiac and other tissues
US9987488B1 (en) 2007-06-27 2018-06-05 Respicardia, Inc. Detecting and treating disordered breathing
EP2164560B8 (en) 2007-06-29 2016-10-12 NewStim, Inc. Systems for cardiac rhythm management using an electrode arrangement
US20090024047A1 (en) 2007-07-20 2009-01-22 Cardiac Pacemakers, Inc. Devices and methods for respiration therapy
US9037239B2 (en) 2007-08-07 2015-05-19 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
US8265736B2 (en) 2007-08-07 2012-09-11 Cardiac Pacemakers, Inc. Method and apparatus to perform electrode combination selection
US7994655B2 (en) 2007-08-17 2011-08-09 Inovise Medical, Inc. Mechanical, anatomical heart-pumping assist
US8135471B2 (en) 2007-08-28 2012-03-13 Cardiac Pacemakers, Inc. Method and apparatus for inspiratory muscle stimulation using implantable device
US8527036B2 (en) 2007-09-28 2013-09-03 Maquet Critical Care Ab Catheter positioning method and computerized control unit for implementing the method
WO2009048610A1 (en) 2007-10-10 2009-04-16 Cardiac Pacemakers, Inc. Respiratory stimulation for treating periodic breathing
WO2009059033A1 (en) 2007-10-30 2009-05-07 Synapse Biomedical, Inc. Method of improving sleep disordered breathing
US8428726B2 (en) 2007-10-30 2013-04-23 Synapse Biomedical, Inc. Device and method of neuromodulation to effect a functionally restorative adaption of the neuromuscular system
JP5452500B2 (en) 2007-11-26 2014-03-26 シー・アール・バード・インコーポレーテッド Integrated system for intravascular placement of catheters
US8406883B1 (en) 2007-12-27 2013-03-26 Boston Scientific Neuromodulation Corporation Lead assembly for electrical stimulation systems and methods of making and using
US20130123891A1 (en) 2008-02-01 2013-05-16 John Swanson High density terminal contacts for stimulation lead and stimulation system employing the same, and method of stimulation lead fabrication
US9199075B1 (en) 2008-02-07 2015-12-01 Respicardia, Inc. Transvascular medical lead
US7925352B2 (en) 2008-03-27 2011-04-12 Synecor Llc System and method for transvascularly stimulating contents of the carotid sheath
US8052607B2 (en) 2008-04-22 2011-11-08 St. Jude Medical, Atrial Fibrillation Division, Inc. Ultrasound imaging catheter with pivoting head
WO2009135082A1 (en) 2008-04-30 2009-11-05 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
WO2009134459A2 (en) 2008-05-02 2009-11-05 The Johns Hopkins University Portable negative pressure ventilation device and methods and software related thereto
US9409012B2 (en) 2008-06-19 2016-08-09 Cardiac Pacemakers, Inc. Pacemaker integrated with vascular intervention catheter
US8239037B2 (en) 2008-07-06 2012-08-07 Synecor Llc Intravascular implant anchors having remote communication and/or battery recharging capabilities
EP2334372A1 (en) 2008-07-08 2011-06-22 Cardiac Pacemakers, Inc. Systems for delivering vagal nerve stimulation
US8734437B2 (en) 2008-07-23 2014-05-27 Boston Scientific Scimed, Inc. Catheter having electrically conductive pathways
JP4545210B2 (en) 2008-09-11 2010-09-15 日本ライフライン株式会社 Defibrillation catheter
WO2010045222A1 (en) 2008-10-13 2010-04-22 E-Pacing, Inc. Devices and methods for electrical stimulation of the diaphragm and nerves
US20100114227A1 (en) 2008-10-30 2010-05-06 Pacesetter, Inc. Systems and Methds for Use by an Implantable Medical Device for Controlling Vagus Nerve Stimulation Based on Heart Rate Reduction Curves and Thresholds to Mitigate Heart Failure
US8386053B2 (en) 2008-10-31 2013-02-26 Medtronic, Inc. Subclavian ansae stimulation
WO2010057026A2 (en) 2008-11-13 2010-05-20 Proteus Biomedical, Inc. Rechargeable stimulation lead, system, and method
JP2012508624A (en) 2008-11-13 2012-04-12 プロテウス バイオメディカル インコーポレイテッド Multiplexed multiple electrode nerve stimulator
US8781578B2 (en) 2008-11-14 2014-07-15 Cardiac Pacemakers, Inc. Mass attribute detection through phrenic stimulation
US8644939B2 (en) 2008-11-18 2014-02-04 Neurostream Technologies General Partnership Method and device for the detection, identification and treatment of sleep apnea/hypopnea
US8995731B2 (en) * 2008-11-26 2015-03-31 Medtronic, Inc. Image-based characterization of implanted medical leads
KR101088806B1 (en) 2009-01-07 2011-12-01 주식회사 뉴로바이오시스 Micro-electrode Array Package using Liquid Crystal Polymer and Manufacturing Method thereof
US20120035684A1 (en) 2009-02-09 2012-02-09 Todd Thompson Multiplexed, Multi-Electrode Neurostimulation Devices with Integrated Circuits Having Integrated Electrodes
US9226689B2 (en) 2009-03-10 2016-01-05 Medtronic Xomed, Inc. Flexible circuit sheet
US9226688B2 (en) 2009-03-10 2016-01-05 Medtronic Xomed, Inc. Flexible circuit assemblies
US20100268311A1 (en) 2009-04-17 2010-10-21 Ralph Cardinal Method for Implanting Electrode on Nerve
US8626292B2 (en) 2009-05-27 2014-01-07 Cardiac Pacemakers, Inc. Respiration sensor processing for phrenic nerve activation detection
US9149642B2 (en) 2009-05-27 2015-10-06 Cardiac Pacemakers, Inc. Method and apparatus for phrenic nerve activation detection with respiration cross-checking
US9532724B2 (en) 2009-06-12 2017-01-03 Bard Access Systems, Inc. Apparatus and method for catheter navigation using endovascular energy mapping
US8694123B2 (en) 2009-06-19 2014-04-08 Medtronic, Inc. Helical electrode arrangements for medical leads
US8340783B2 (en) 2009-06-30 2012-12-25 Medtronic, Inc. Implantable medical device lead with selectively exposed electrodes and reinforcement member
CA2770151A1 (en) 2009-08-05 2011-02-10 Ndi Medical, Llc Systems and methods for maintaining airway patency
US8644952B2 (en) 2009-09-02 2014-02-04 Cardiac Pacemakers, Inc. Medical devices including polyisobutylene based polymers and derivatives thereof
US8374704B2 (en) 2009-09-02 2013-02-12 Cardiac Pacemakers, Inc. Polyisobutylene urethane, urea and urethane/urea copolymers and medical leads containing the same
US9072899B1 (en) 2009-09-04 2015-07-07 Todd Nickloes Diaphragm pacemaker
US8233987B2 (en) 2009-09-10 2012-07-31 Respicardia, Inc. Respiratory rectification
US9468755B2 (en) 2009-09-30 2016-10-18 Respicardia, Inc. Medical lead with preformed bias
US8617228B2 (en) 2009-10-23 2013-12-31 Medtronic Cryocath Lp Method and system for preventing nerve injury during a medical procedure
US8676308B2 (en) * 2009-11-03 2014-03-18 Boston Scientific Neuromodulation Corporation System and method for mapping arbitrary electric fields to pre-existing lead electrodes
CN102821676B (en) 2010-01-29 2016-09-07 C·R·巴德股份有限公司 Sacrifice conduit
BR112012019354B1 (en) 2010-02-02 2021-09-08 C.R.Bard, Inc METHOD FOR LOCATION OF AN IMPLANTABLE MEDICAL DEVICE
US8753333B2 (en) 2010-03-10 2014-06-17 Covidien Lp System for determining proximity relative to a nerve
JP5537213B2 (en) 2010-03-26 2014-07-02 オリンパス株式会社 Electrical stimulation electrode assembly
US20110230945A1 (en) 2010-03-19 2011-09-22 Olympus Corporation Electrostimulation system, and electrostimulation electrode assembly and biological implantable electrode therefor
US10631912B2 (en) 2010-04-30 2020-04-28 Medtronic Xomed, Inc. Interface module for use with nerve monitoring and electrosurgery
US20110270358A1 (en) 2010-04-30 2011-11-03 Medtronic, Inc. Implantable medical device programming using gesture-based control
US8755889B2 (en) 2010-04-30 2014-06-17 Medtronic, Inc. Method and apparatus to enhance therapy during stimulation of vagus nerve
AU2011261702B2 (en) 2010-06-03 2014-11-27 Cardiac Pacemakers, Inc. System for controlling target of neurostimulation using temporal parameters
WO2011153024A1 (en) 2010-06-03 2011-12-08 Cardiac Pacemakers, Inc. System for spatially selective vagus nerve stimulation
JP4940332B2 (en) 2010-06-15 2012-05-30 日本ライフライン株式会社 catheter
US20120130217A1 (en) 2010-11-23 2012-05-24 Kauphusman James V Medical devices having electrodes mounted thereon and methods of manufacturing therefor
CN102958562B (en) 2010-06-30 2015-05-27 Med-El电气医疗器械有限公司 Ear implant electrode and method of manufacture
WO2012012432A1 (en) 2010-07-19 2012-01-26 Cardiac Pacemakers, Inc. Minimally invasive lead system for vagus nerve stimulation
WO2012015621A1 (en) 2010-07-29 2012-02-02 Boston Scientific Neuromodulation Corporation Systems and methods for making and using electrical stimulation systems having multi-lead-element lead bodies
WO2012019036A1 (en) 2010-08-06 2012-02-09 Cardiac Pacemakers, Inc. User interface system for use with multipolar pacing leads
US8934956B2 (en) 2010-08-31 2015-01-13 Interventional Autonomics Corporation Intravascular electrodes and anchoring devices for transvascular stimulation
US20120078320A1 (en) 2010-09-29 2012-03-29 Medtronic, Inc. Prioritized programming of multi-electrode pacing leads
KR101304338B1 (en) 2010-10-21 2013-09-11 주식회사 엠아이텍 LCP-based electro-optrode neural interface and Method for fabricating the same
WO2012058461A1 (en) 2010-10-29 2012-05-03 C.R.Bard, Inc. Bioimpedance-assisted placement of a medical device
US8391956B2 (en) 2010-11-18 2013-03-05 Robert D. Zellers Medical device location systems, devices and methods
US8560086B2 (en) 2010-12-02 2013-10-15 St. Jude Medical, Atrial Fibrillation Division, Inc. Catheter electrode assemblies and methods of construction therefor
US8781583B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8781582B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8725259B2 (en) 2011-01-19 2014-05-13 Medtronic, Inc. Vagal stimulation
US8718763B2 (en) 2011-01-19 2014-05-06 Medtronic, Inc. Vagal stimulation
US8706223B2 (en) 2011-01-19 2014-04-22 Medtronic, Inc. Preventative vagal stimulation
US9174046B2 (en) 2011-01-25 2015-11-03 Cedric Francois Apparatus and methods for assisting breathing
US9550041B2 (en) 2011-02-04 2017-01-24 Advanced Pain Center, Llc. Continuous single wire steerable catheter
US9744349B2 (en) 2011-02-10 2017-08-29 Respicardia, Inc. Medical lead and implantation
US8430864B2 (en) 2011-02-16 2013-04-30 Biosense Webster, Inc. Catheter with multiple deflections
US8504158B2 (en) 2011-05-09 2013-08-06 Medtronic, Inc. Phrenic nerve stimulation during cardiac refractory period
US9446240B2 (en) * 2011-07-11 2016-09-20 Interventional Autonomics Corporation System and method for neuromodulation
US9615759B2 (en) 2011-07-12 2017-04-11 Bard Access Systems, Inc. Devices and methods for ECG guided vascular access
US20130018427A1 (en) 2011-07-15 2013-01-17 Khiem Pham Screw Implants For Bone Fusion
US8805511B2 (en) 2011-07-27 2014-08-12 Medtronic, Inc. Method and apparatus to detect subcerebral ischemia
US20130030497A1 (en) 2011-07-27 2013-01-31 Medtronic, Inc. Nerve stimulator for reduced muscle fatigue
US8478413B2 (en) 2011-07-27 2013-07-02 Medtronic, Inc. Bilateral phrenic nerve stimulation with reduced dyssynchrony
US9861817B2 (en) 2011-07-28 2018-01-09 Medtronic, Inc. Medical device to provide breathing therapy
US8509902B2 (en) 2011-07-28 2013-08-13 Medtronic, Inc. Medical device to provide breathing therapy
US10201385B2 (en) 2011-09-01 2019-02-12 Biosense Webster (Israel) Ltd. Catheter adapted for direct tissue contact
US9724018B2 (en) 2011-10-27 2017-08-08 Medtronic Cryocath Lp Method for monitoring phrenic nerve function
US8897879B2 (en) 2011-11-04 2014-11-25 Medtronic, Inc. Method and apparatus for therapies of the cardiovascular and cardiorenal system
EP3287067B1 (en) 2011-11-07 2019-10-30 Medtronic Ardian Luxembourg S.à.r.l. Endovascular nerve monitoring devices and associated systems
US9956396B2 (en) 2012-02-08 2018-05-01 Medtronic Bakken Research Center B.V. Thin film for a lead for brain applications
EP3228351B1 (en) 2012-03-05 2019-06-05 Lungpacer Medical Inc. Transvascular nerve stimulation apparatus
EP2827944B1 (en) 2012-03-21 2016-05-18 Cardiac Pacemakers, Inc. Systems and methods for stimulation of vagus nerve
US10413203B2 (en) 2012-03-27 2019-09-17 Cardiac Pacemakers, Inc. Baseline determination for phrenic nerve stimulation detection
WO2013165920A1 (en) 2012-04-29 2013-11-07 Synecor Llc Intravascular electrode arrays for neuromodulation
US9179972B2 (en) 2012-05-04 2015-11-10 St. Jude Medical, Atrial Fibrillation Division, Inc. System and method for controlling delivery of ablation energy to tissue
WO2013177145A1 (en) 2012-05-25 2013-11-28 Boston Scientific Neuromodulation Corporation Methods for stimulating the dorsal root ganglion with a lead having segmented electrodes
CN104684614B (en) 2012-06-21 2017-10-17 西蒙·弗雷泽大学 The diaphragm pacing system and application method of intravascular
WO2014008171A1 (en) 2012-07-02 2014-01-09 Medisci L.L.C. Method and device for respiratory and cardiorespiratory support
US8504161B1 (en) 2012-08-07 2013-08-06 Medtronic, Inc. Modulate vagal signals to reduce inflammation
JP2015531628A (en) 2012-08-20 2015-11-05 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. Synchronization of mechanical forced inspiration exhalation and diaphragmatic pacing
EP2722071A1 (en) 2012-10-16 2014-04-23 Sapiens Steering Brain Stimulation B.V. A probe, especially a probe for neural applications
US20140121716A1 (en) 2012-10-31 2014-05-01 Medtronic, Inc. High voltage therapy diversion algorithms
US20150290476A1 (en) 2012-11-05 2015-10-15 Jesus Arturo Cabrera Non-invasive lung pacing
CN102949770B (en) 2012-11-09 2015-04-22 张红璇 External diaphragm pacing and breathing machine synergistic air supply method and device thereof
US9072864B2 (en) 2012-11-28 2015-07-07 Ad-Tech Medical Instrument Corporation Catheter with depth electrode for dual-purpose use
EP4201469A1 (en) 2012-12-05 2023-06-28 Battelle Memorial Institute Neuromuscular stimulation cuff
US9884179B2 (en) 2012-12-05 2018-02-06 Bbattelle Memorial Institute Neural sleeve for neuromuscular stimulation, sensing and recording
US10335592B2 (en) 2012-12-19 2019-07-02 Viscardia, Inc. Systems, devices, and methods for improving hemodynamic performance through asymptomatic diaphragm stimulation
WO2014099820A1 (en) 2012-12-19 2014-06-26 Inovise Medical, Inc. Hemodynamic performance enhancement through asymptomatic diaphragm stimulation
US9485873B2 (en) 2013-03-15 2016-11-01 Lawrence Livermore National Security, Llc Depositing bulk or micro-scale electrodes
EP2818104B1 (en) 2013-06-25 2016-01-06 VascoMed GmbH Catheter and method for producing same
US9427566B2 (en) 2013-08-14 2016-08-30 Syntilla Medical LLC Implantable neurostimulation lead for head pain
US10058697B2 (en) 2013-08-27 2018-08-28 Advanced Bionics Ag Thermoformed electrode arrays
US9504837B2 (en) 2013-10-25 2016-11-29 Medtronic, Inc. Automated phrenic nerve stimulation and pacing capture threshold test
US9205258B2 (en) 2013-11-04 2015-12-08 ElectroCore, LLC Nerve stimulator system
AU2014351473B2 (en) 2013-11-22 2019-11-07 Lungpacer Medical Inc. Apparatus and methods for assisted breathing by transvascular nerve stimulation
WO2015106116A1 (en) 2014-01-10 2015-07-16 Boston Scientific Scimed, Inc. Medical devices with flexible circuit assemblies
EP3566743B1 (en) 2014-01-21 2021-03-10 Lungpacer Medical Inc. Systems for optimization of multi-electrode nerve pacing
US9498631B2 (en) 2014-02-20 2016-11-22 Medtronic, Inc. Automated phrenic nerve stimulation and pacing capture threshold test
US9844644B2 (en) 2014-03-05 2017-12-19 Oscor Inc. Intravascular sheath with mapping capabilities to deliver therapeutic devices to a targeted location within a blood vessel
US20160310730A1 (en) 2014-03-28 2016-10-27 Antonio Garcia Martins Stimulation system for exercising diaphragm and method of operation thereof
US10194978B2 (en) 2014-06-13 2019-02-05 Medtronic Cryocath Lp Supporting catheter for use for phrenic nerve pacing
KR101654801B1 (en) 2014-08-08 2016-09-07 서울대학교산학협력단 Microelectrode array and package for liquid crystal polymer based neuroprostheses and manufacturing method thereof
WO2016033245A1 (en) 2014-08-26 2016-03-03 Rmx, Llc Devices and methods for reducing intrathoracic pressure
US9474894B2 (en) 2014-08-27 2016-10-25 Aleva Neurotherapeutics Deep brain stimulation lead
CN107205641A (en) 2014-08-29 2017-09-26 因赛飞公司 Method and apparatus for strengthening nervous function
US10507321B2 (en) 2014-11-25 2019-12-17 Medtronic Bakken Research Center B.V. Multilayer structure and method of manufacturing a multilayer structure
US20160331326A1 (en) 2015-02-13 2016-11-17 National University Of Singapore Flexible neural strip electrodes, flexible neural ribbon electrodes and compartment based embedded nerve tissue electrode interfaces for peripheral nerves
US10622107B2 (en) 2015-02-13 2020-04-14 Medtronic, Inc. Tools for medical device configuration
EP3064131A1 (en) 2015-03-03 2016-09-07 BIOTRONIK SE & Co. KG Combined vagus-phrenic nerve stimulation apparatus
US9872989B2 (en) 2015-04-02 2018-01-23 The Florida International University Board Of Trustees System and method for neuromorphic controlled adaptive pacing of respiratory muscles and nerves
CN107921255B (en) 2015-07-30 2021-02-26 波士顿科学神经调制公司 User interface for custom-patterned electrical stimulation
JP7039038B2 (en) 2015-12-14 2022-03-22 スティムディア メディカル, インコーポレイテッド Electrical stimulation for retention and restoration of diaphragmatic function
US10537735B2 (en) 2016-04-29 2020-01-21 Viscardia, Inc. Implantable medical devices and methods for real-time or near real-time adjustment of diaphragmatic stimulation parameters to affect pressures within the intrathoracic cavity
US10695564B2 (en) 2016-06-02 2020-06-30 Battelle Memorial Institute Flexible sheet for neuromuscular stimulation
US10492713B2 (en) 2016-06-03 2019-12-03 The Cleveland Clinic Foundation Systems and methods for monitoring a depth of neuromuscular blockade
US10207103B2 (en) 2016-07-05 2019-02-19 Pacesetter, Inc. Implantable thin film devices
US10898262B2 (en) 2016-10-25 2021-01-26 Biosense Webster (Israel) Ltd. Catheter distal end made of plastic tube and flexible printed circuit boards
US10293164B2 (en) 2017-05-26 2019-05-21 Lungpacer Medical Inc. Apparatus and methods for assisted breathing by transvascular nerve stimulation
US10195429B1 (en) 2017-08-02 2019-02-05 Lungpacer Medical Inc. Systems and methods for intravascular catheter positioning and/or nerve stimulation
AU2019217570A1 (en) 2018-02-06 2020-09-03 Stimit Ag Electro-magnetic induction device and method of activating a target tissue

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8706235B2 (en) * 2011-07-27 2014-04-22 Medtronic, Inc. Transvenous method to induce respiration

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022179976A1 (en) * 2021-02-23 2022-09-01 B. Braun Melsungen Ag Method for checking a position and/or an orientation of a catheter tip of a catheter

Also Published As

Publication number Publication date
US20190126038A1 (en) 2019-05-02
WO2019027757A2 (en) 2019-02-07
US10039920B1 (en) 2018-08-07
US11090489B2 (en) 2021-08-17
US10195429B1 (en) 2019-02-05
US20210330968A1 (en) 2021-10-28
US10926087B2 (en) 2021-02-23
JP7175027B2 (en) 2022-11-18
EP3661589A2 (en) 2020-06-10
CN111225710A (en) 2020-06-02
AU2018309630A1 (en) 2020-03-19
JP2020529264A (en) 2020-10-08
US20200188658A1 (en) 2020-06-18

Similar Documents

Publication Publication Date Title
US10926087B2 (en) Systems and methods for intravascular catheter positioning and/or nerve stimulation
US11311730B2 (en) Systems and related methods for optimization of multi-electrode nerve pacing
US11883658B2 (en) Devices and methods for prevention, moderation, and/or treatment of cognitive injury
JP7462946B2 (en) Systems and methods for strengthening respiratory muscles

Legal Events

Date Code Title Description
AS Assignment

Owner name: LUNGPACER MEDICAL INC., CANADA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:THAKKAR, VIRAL S.;EVANS, DOUGLAS G.;GANI, MATTHEW J.;SIGNING DATES FROM 20170802 TO 20170803;REEL/FRAME:043211/0555

STCF Information on status: patent grant

Free format text: PATENTED CASE

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY

Year of fee payment: 4